<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/45EC8957-58E0-42E0-9073-ED5C3759E882"><gtr:id>45EC8957-58E0-42E0-9073-ED5C3759E882</gtr:id><gtr:name>Lambeth College</gtr:name><gtr:address><gtr:line1>Clapham Centre</gtr:line1><gtr:line2>45 Clapham Common South Side</gtr:line2><gtr:postCode>SW4 9BL</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93FAFD7C-943C-4733-8AA0-9D9B7BAD5B9D"><gtr:id>93FAFD7C-943C-4733-8AA0-9D9B7BAD5B9D</gtr:id><gtr:name>Bradford Teaching Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BF13226-370C-485A-BFF2-C32F792AEDCD"><gtr:id>5BF13226-370C-485A-BFF2-C32F792AEDCD</gtr:id><gtr:name>CROMSOURCE</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FE24BCA5-13DD-4976-B7C1-A1D060CB7A8E"><gtr:id>FE24BCA5-13DD-4976-B7C1-A1D060CB7A8E</gtr:id><gtr:name>North East London NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Tantallon House</gtr:line1><gtr:line2>Goodmayes Hospital Site</gtr:line2><gtr:line3>Barley Lane</gtr:line3><gtr:postCode>IG3 8XJ</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F"><gtr:id>A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F</gtr:id><gtr:name>Epistem</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A75EF746-05EF-4C54-9701-C4485DDEEE6B"><gtr:id>A75EF746-05EF-4C54-9701-C4485DDEEE6B</gtr:id><gtr:name>Oxford Gene Technology</gtr:name><gtr:address><gtr:line1>Begbroke Science Park
Sandy Lane
Yarnton</gtr:line1><gtr:city>Oxford</gtr:city><gtr:postCode>OX5 1PF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF4393D0-F67D-48F9-B944-1498ABC3FDEA"><gtr:id>BF4393D0-F67D-48F9-B944-1498ABC3FDEA</gtr:id><gtr:name>Northern Devon Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30"><gtr:id>E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30</gtr:id><gtr:name>QUANTUMDX Group Limited</gtr:name><gtr:address><gtr:line1>International Centre for Life</gtr:line1><gtr:line2>Times Square</gtr:line2><gtr:postCode>NE1 4EP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A6345ED-A4B9-472D-B7D8-D12B3AB4344C"><gtr:id>0A6345ED-A4B9-472D-B7D8-D12B3AB4344C</gtr:id><gtr:name>Hertfordshire Community NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE23BD2-8F03-4E55-AA41-768D2AF6AF85"><gtr:id>5EE23BD2-8F03-4E55-AA41-768D2AF6AF85</gtr:id><gtr:name>NIHR Diagnostic Evidence Co-operatve</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBC49A63-F0CC-4C8F-A3E3-AFAE6FD5FA98"><gtr:id>DBC49A63-F0CC-4C8F-A3E3-AFAE6FD5FA98</gtr:id><gtr:name>iBOSSolutions Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D052D2E1-5EE0-4392-857B-84A04BEB1D4C"><gtr:id>D052D2E1-5EE0-4392-857B-84A04BEB1D4C</gtr:id><gtr:name>Atlas Genetics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F453931A-63E1-4AD2-993E-FFF142B1C88B"><gtr:id>F453931A-63E1-4AD2-993E-FFF142B1C88B</gtr:id><gtr:name>Axxin</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80ABD8F4-FC22-47D8-BAFE-6F8D1114D2CC"><gtr:id>80ABD8F4-FC22-47D8-BAFE-6F8D1114D2CC</gtr:id><gtr:name>West Middlesex University Hospital</gtr:name><gtr:address><gtr:line1>University of Middlesex</gtr:line1><gtr:line2>Twickenham Road</gtr:line2><gtr:postCode>TW7 6AF</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A6772282-59BF-404C-8FED-97C444A6F1A9"><gtr:id>A6772282-59BF-404C-8FED-97C444A6F1A9</gtr:id><gtr:name>Dorset County Hospital NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BABA75A9-B7E8-4D4B-A8E6-2CCC0A6777D3"><gtr:id>BABA75A9-B7E8-4D4B-A8E6-2CCC0A6777D3</gtr:id><gtr:name>Mologic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37B04F53-AFDA-41A8-8216-1EEE7410C7DC"><gtr:id>37B04F53-AFDA-41A8-8216-1EEE7410C7DC</gtr:id><gtr:name>Leicester Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/14EB02E5-BEC0-4CCC-8EF4-CCECDD113817"><gtr:id>14EB02E5-BEC0-4CCC-8EF4-CCECDD113817</gtr:id><gtr:name>St George's NHS Trust, London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EFA2059D-73E3-4989-9D54-188E5DB50EB6"><gtr:id>EFA2059D-73E3-4989-9D54-188E5DB50EB6</gtr:id><gtr:name>Cepheid</gtr:name><gtr:address><gtr:line1>904 Caribbean Drive</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A484113-93AB-4013-81BA-34AFEEBDC64F"><gtr:id>1A484113-93AB-4013-81BA-34AFEEBDC64F</gtr:id><gtr:name>Knight Scientific Ltd</gtr:name><gtr:address><gtr:line1>Knight Scientific Ltd</gtr:line1><gtr:line2>The Laboratory</gtr:line2><gtr:line3>18 Western College Road</gtr:line3><gtr:postCode>PL4 7AG</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/10B24458-606C-4BE8-925D-46DA627A49B8"><gtr:id>10B24458-606C-4BE8-925D-46DA627A49B8</gtr:id><gtr:name>Alere</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/839E5DAA-F3A9-4FCA-BC3A-A537F96D2C57"><gtr:id>839E5DAA-F3A9-4FCA-BC3A-A537F96D2C57</gtr:id><gtr:name>National Institute for Health and Care Excellence (NICE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/252189B3-135F-4D99-BFB7-0799A34A409C"><gtr:id>252189B3-135F-4D99-BFB7-0799A34A409C</gtr:id><gtr:name>Loughborough University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1187A42-546F-4206-B285-9A24ECB23643"><gtr:id>A1187A42-546F-4206-B285-9A24ECB23643</gtr:id><gtr:name>Safeguard Biosystems</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D4FFEFED-8795-470D-95A7-57770CDEAFEA"><gtr:id>D4FFEFED-8795-470D-95A7-57770CDEAFEA</gtr:id><gtr:name>Quidel</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61CB5E11-A623-4BCD-AC4F-263CC0BBA018"><gtr:id>61CB5E11-A623-4BCD-AC4F-263CC0BBA018</gtr:id><gtr:name>MINISTRY OF PUBLIC HEALTH</gtr:name><gtr:address><gtr:line1>MINISTRY OF PUBLIC HEALTH</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4AE6001-1347-4246-84A7-81408473BD3B"><gtr:id>C4AE6001-1347-4246-84A7-81408473BD3B</gtr:id><gtr:name>Royal Cornwall Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Royal Cornwall Hospital</gtr:line1><gtr:line2>Treliske</gtr:line2><gtr:postCode>TR1 3LJ</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DD68C71-6946-40A2-B245-AF543E956C1E"><gtr:id>3DD68C71-6946-40A2-B245-AF543E956C1E</gtr:id><gtr:name>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CC15D926-BA27-4846-B5CB-D22F6AAC63B7"><gtr:id>CC15D926-BA27-4846-B5CB-D22F6AAC63B7</gtr:id><gtr:name>Moorlodge Biotech Ventures</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B85410DE-F447-4BDE-A92D-5836E475A101"><gtr:id>B85410DE-F447-4BDE-A92D-5836E475A101</gtr:id><gtr:name>Aquarius Population Health Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B21EA61E-8062-4809-8E60-AD9A277C265A"><gtr:id>B21EA61E-8062-4809-8E60-AD9A277C265A</gtr:id><gtr:name>TwistDx</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/52D47D67-C160-4C09-A5A6-03E1C35E47D5"><gtr:id>52D47D67-C160-4C09-A5A6-03E1C35E47D5</gtr:id><gtr:name>Royal Hallamshire Hospital</gtr:name><gtr:address><gtr:line1>Glossop Road</gtr:line1><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2JF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3A22EAB-D597-464D-BFBF-9507247B563C"><gtr:id>E3A22EAB-D597-464D-BFBF-9507247B563C</gtr:id><gtr:name>BJS Biotechnologies Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D657B59F-F040-46B5-A35B-D457C06CE596"><gtr:id>D657B59F-F040-46B5-A35B-D457C06CE596</gtr:id><gtr:name>Becton, Dickinson and Company (BD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C705F4C9-3E9D-4C2A-90B0-49C636E962EE"><gtr:id>C705F4C9-3E9D-4C2A-90B0-49C636E962EE</gtr:id><gtr:name>Barts Health NHS Trust</gtr:name><gtr:address><gtr:line1>9 Prescot Street
Aldgate</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>E1 8PR</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C77CC3AB-E07D-4760-8F1B-8AB2E488851B"><gtr:id>C77CC3AB-E07D-4760-8F1B-8AB2E488851B</gtr:id><gtr:name>3QBD</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FDB6D920-E33E-4870-9B78-BBFBAD79A3D3"><gtr:id>FDB6D920-E33E-4870-9B78-BBFBAD79A3D3</gtr:id><gtr:name>SpeedDX Pty</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9F389987-5CF8-4C31-B2E6-C5EE5CA19D4E"><gtr:id>9F389987-5CF8-4C31-B2E6-C5EE5CA19D4E</gtr:id><gtr:name>St George's Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/303E2392-4064-48A4-99F4-4ADB9D75C377"><gtr:id>303E2392-4064-48A4-99F4-4ADB9D75C377</gtr:id><gtr:name>St George's Hospital</gtr:name><gtr:address><gtr:line1>Blackshaw Road</gtr:line1><gtr:line2>Tooting</gtr:line2><gtr:postCode>SW17 0QT</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE7AA11B-92BD-420C-A36C-986745F99224"><gtr:id>AE7AA11B-92BD-420C-A36C-986745F99224</gtr:id><gtr:name>Taunton and Somerset NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9BE6F2A-7F69-4499-8DCC-04808C493698"><gtr:id>A9BE6F2A-7F69-4499-8DCC-04808C493698</gtr:id><gtr:name>Qiagen</gtr:name><gtr:address><gtr:line1>QIAGEN GmbH</gtr:line1><gtr:line2>QIAGEN Strasse 1</gtr:line2><gtr:postCode>40724</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/15181332-852E-44F9-88E7-E0B626980883"><gtr:id>15181332-852E-44F9-88E7-E0B626980883</gtr:id><gtr:name>Solent NHS Trust</gtr:name><gtr:address><gtr:line1>Adelaide Health Centre
William Macleod Way
Millbrook</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 4XE</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C438AC0-4F4B-4808-BD8B-A73CF4EFF266"><gtr:id>9C438AC0-4F4B-4808-BD8B-A73CF4EFF266</gtr:id><gtr:name>Central London Community Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1886BADE-63D6-4F8E-94F2-06E330F05A49"><gtr:id>1886BADE-63D6-4F8E-94F2-06E330F05A49</gtr:id><gtr:name>Lloyds Pharmacy</gtr:name><gtr:address><gtr:line1>Sapphire Court</gtr:line1><gtr:line2>Paradise Way</gtr:line2><gtr:line3>Coventry Walsgrave Triangle</gtr:line3><gtr:postCode>CV2 2TX</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:department>Cellular and Molecular Medicine</gtr:department><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/45EC8957-58E0-42E0-9073-ED5C3759E882"><gtr:id>45EC8957-58E0-42E0-9073-ED5C3759E882</gtr:id><gtr:name>Lambeth College</gtr:name><gtr:address><gtr:line1>Clapham Centre</gtr:line1><gtr:line2>45 Clapham Common South Side</gtr:line2><gtr:postCode>SW4 9BL</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93FAFD7C-943C-4733-8AA0-9D9B7BAD5B9D"><gtr:id>93FAFD7C-943C-4733-8AA0-9D9B7BAD5B9D</gtr:id><gtr:name>Bradford Teaching Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BF13226-370C-485A-BFF2-C32F792AEDCD"><gtr:id>5BF13226-370C-485A-BFF2-C32F792AEDCD</gtr:id><gtr:name>CROMSOURCE</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FE24BCA5-13DD-4976-B7C1-A1D060CB7A8E"><gtr:id>FE24BCA5-13DD-4976-B7C1-A1D060CB7A8E</gtr:id><gtr:name>North East London NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Tantallon House</gtr:line1><gtr:line2>Goodmayes Hospital Site</gtr:line2><gtr:line3>Barley Lane</gtr:line3><gtr:postCode>IG3 8XJ</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F"><gtr:id>A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F</gtr:id><gtr:name>Epistem</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A75EF746-05EF-4C54-9701-C4485DDEEE6B"><gtr:id>A75EF746-05EF-4C54-9701-C4485DDEEE6B</gtr:id><gtr:name>Oxford Gene Technology</gtr:name><gtr:address><gtr:line1>Begbroke Science Park
Sandy Lane
Yarnton</gtr:line1><gtr:city>Oxford</gtr:city><gtr:postCode>OX5 1PF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF4393D0-F67D-48F9-B944-1498ABC3FDEA"><gtr:id>BF4393D0-F67D-48F9-B944-1498ABC3FDEA</gtr:id><gtr:name>Northern Devon Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30"><gtr:id>E91EA92B-76A4-4BA2-BDB0-4978BC6F7E30</gtr:id><gtr:name>QUANTUMDX Group Limited</gtr:name><gtr:address><gtr:line1>International Centre for Life</gtr:line1><gtr:line2>Times Square</gtr:line2><gtr:postCode>NE1 4EP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A6345ED-A4B9-472D-B7D8-D12B3AB4344C"><gtr:id>0A6345ED-A4B9-472D-B7D8-D12B3AB4344C</gtr:id><gtr:name>Hertfordshire Community NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE23BD2-8F03-4E55-AA41-768D2AF6AF85"><gtr:id>5EE23BD2-8F03-4E55-AA41-768D2AF6AF85</gtr:id><gtr:name>NIHR Diagnostic Evidence Co-operatve</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBC49A63-F0CC-4C8F-A3E3-AFAE6FD5FA98"><gtr:id>DBC49A63-F0CC-4C8F-A3E3-AFAE6FD5FA98</gtr:id><gtr:name>iBOSSolutions Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D052D2E1-5EE0-4392-857B-84A04BEB1D4C"><gtr:id>D052D2E1-5EE0-4392-857B-84A04BEB1D4C</gtr:id><gtr:name>Atlas Genetics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F453931A-63E1-4AD2-993E-FFF142B1C88B"><gtr:id>F453931A-63E1-4AD2-993E-FFF142B1C88B</gtr:id><gtr:name>Axxin</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80ABD8F4-FC22-47D8-BAFE-6F8D1114D2CC"><gtr:id>80ABD8F4-FC22-47D8-BAFE-6F8D1114D2CC</gtr:id><gtr:name>West Middlesex University Hospital</gtr:name><gtr:address><gtr:line1>University of Middlesex</gtr:line1><gtr:line2>Twickenham Road</gtr:line2><gtr:postCode>TW7 6AF</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A6772282-59BF-404C-8FED-97C444A6F1A9"><gtr:id>A6772282-59BF-404C-8FED-97C444A6F1A9</gtr:id><gtr:name>Dorset County Hospital NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BABA75A9-B7E8-4D4B-A8E6-2CCC0A6777D3"><gtr:id>BABA75A9-B7E8-4D4B-A8E6-2CCC0A6777D3</gtr:id><gtr:name>Mologic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37B04F53-AFDA-41A8-8216-1EEE7410C7DC"><gtr:id>37B04F53-AFDA-41A8-8216-1EEE7410C7DC</gtr:id><gtr:name>Leicester Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/14EB02E5-BEC0-4CCC-8EF4-CCECDD113817"><gtr:id>14EB02E5-BEC0-4CCC-8EF4-CCECDD113817</gtr:id><gtr:name>St George's NHS Trust, London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EFA2059D-73E3-4989-9D54-188E5DB50EB6"><gtr:id>EFA2059D-73E3-4989-9D54-188E5DB50EB6</gtr:id><gtr:name>Cepheid</gtr:name><gtr:address><gtr:line1>904 Caribbean Drive</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A484113-93AB-4013-81BA-34AFEEBDC64F"><gtr:id>1A484113-93AB-4013-81BA-34AFEEBDC64F</gtr:id><gtr:name>Knight Scientific Ltd</gtr:name><gtr:address><gtr:line1>Knight Scientific Ltd</gtr:line1><gtr:line2>The Laboratory</gtr:line2><gtr:line3>18 Western College Road</gtr:line3><gtr:postCode>PL4 7AG</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/10B24458-606C-4BE8-925D-46DA627A49B8"><gtr:id>10B24458-606C-4BE8-925D-46DA627A49B8</gtr:id><gtr:name>Alere</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/839E5DAA-F3A9-4FCA-BC3A-A537F96D2C57"><gtr:id>839E5DAA-F3A9-4FCA-BC3A-A537F96D2C57</gtr:id><gtr:name>National Institute for Health and Care Excellence (NICE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/252189B3-135F-4D99-BFB7-0799A34A409C"><gtr:id>252189B3-135F-4D99-BFB7-0799A34A409C</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1187A42-546F-4206-B285-9A24ECB23643"><gtr:id>A1187A42-546F-4206-B285-9A24ECB23643</gtr:id><gtr:name>Safeguard Biosystems</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D4FFEFED-8795-470D-95A7-57770CDEAFEA"><gtr:id>D4FFEFED-8795-470D-95A7-57770CDEAFEA</gtr:id><gtr:name>Quidel</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61CB5E11-A623-4BCD-AC4F-263CC0BBA018"><gtr:id>61CB5E11-A623-4BCD-AC4F-263CC0BBA018</gtr:id><gtr:name>MINISTRY OF PUBLIC HEALTH</gtr:name><gtr:address><gtr:line1>MINISTRY OF PUBLIC HEALTH</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4AE6001-1347-4246-84A7-81408473BD3B"><gtr:id>C4AE6001-1347-4246-84A7-81408473BD3B</gtr:id><gtr:name>Royal Cornwall Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Royal Cornwall Hospital</gtr:line1><gtr:line2>Treliske</gtr:line2><gtr:postCode>TR1 3LJ</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DD68C71-6946-40A2-B245-AF543E956C1E"><gtr:id>3DD68C71-6946-40A2-B245-AF543E956C1E</gtr:id><gtr:name>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CC15D926-BA27-4846-B5CB-D22F6AAC63B7"><gtr:id>CC15D926-BA27-4846-B5CB-D22F6AAC63B7</gtr:id><gtr:name>Moorlodge Biotech Ventures</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B85410DE-F447-4BDE-A92D-5836E475A101"><gtr:id>B85410DE-F447-4BDE-A92D-5836E475A101</gtr:id><gtr:name>Aquarius Population Health Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B21EA61E-8062-4809-8E60-AD9A277C265A"><gtr:id>B21EA61E-8062-4809-8E60-AD9A277C265A</gtr:id><gtr:name>TwistDx</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/52D47D67-C160-4C09-A5A6-03E1C35E47D5"><gtr:id>52D47D67-C160-4C09-A5A6-03E1C35E47D5</gtr:id><gtr:name>Royal Hallamshire Hospital</gtr:name><gtr:address><gtr:line1>Glossop Road</gtr:line1><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2JF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3A22EAB-D597-464D-BFBF-9507247B563C"><gtr:id>E3A22EAB-D597-464D-BFBF-9507247B563C</gtr:id><gtr:name>BJS Biotechnologies Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D657B59F-F040-46B5-A35B-D457C06CE596"><gtr:id>D657B59F-F040-46B5-A35B-D457C06CE596</gtr:id><gtr:name>Becton, Dickinson and Company (BD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C705F4C9-3E9D-4C2A-90B0-49C636E962EE"><gtr:id>C705F4C9-3E9D-4C2A-90B0-49C636E962EE</gtr:id><gtr:name>Barts Health NHS Trust</gtr:name><gtr:address><gtr:line1>9 Prescot Street
Aldgate</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>E1 8PR</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C77CC3AB-E07D-4760-8F1B-8AB2E488851B"><gtr:id>C77CC3AB-E07D-4760-8F1B-8AB2E488851B</gtr:id><gtr:name>3QBD</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FDB6D920-E33E-4870-9B78-BBFBAD79A3D3"><gtr:id>FDB6D920-E33E-4870-9B78-BBFBAD79A3D3</gtr:id><gtr:name>SpeedDX Pty</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F389987-5CF8-4C31-B2E6-C5EE5CA19D4E"><gtr:id>9F389987-5CF8-4C31-B2E6-C5EE5CA19D4E</gtr:id><gtr:name>St George's Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/303E2392-4064-48A4-99F4-4ADB9D75C377"><gtr:id>303E2392-4064-48A4-99F4-4ADB9D75C377</gtr:id><gtr:name>St George's Hospital</gtr:name><gtr:address><gtr:line1>Blackshaw Road</gtr:line1><gtr:line2>Tooting</gtr:line2><gtr:postCode>SW17 0QT</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE7AA11B-92BD-420C-A36C-986745F99224"><gtr:id>AE7AA11B-92BD-420C-A36C-986745F99224</gtr:id><gtr:name>Taunton and Somerset NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9BE6F2A-7F69-4499-8DCC-04808C493698"><gtr:id>A9BE6F2A-7F69-4499-8DCC-04808C493698</gtr:id><gtr:name>Qiagen</gtr:name><gtr:address><gtr:line1>QIAGEN GmbH</gtr:line1><gtr:line2>QIAGEN Strasse 1</gtr:line2><gtr:postCode>40724</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/15181332-852E-44F9-88E7-E0B626980883"><gtr:id>15181332-852E-44F9-88E7-E0B626980883</gtr:id><gtr:name>Solent NHS Trust</gtr:name><gtr:address><gtr:line1>Adelaide Health Centre
William Macleod Way
Millbrook</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 4XE</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C438AC0-4F4B-4808-BD8B-A73CF4EFF266"><gtr:id>9C438AC0-4F4B-4808-BD8B-A73CF4EFF266</gtr:id><gtr:name>Central London Community Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1886BADE-63D6-4F8E-94F2-06E330F05A49"><gtr:id>1886BADE-63D6-4F8E-94F2-06E330F05A49</gtr:id><gtr:name>Lloyds Pharmacy</gtr:name><gtr:address><gtr:line1>Sapphire Court</gtr:line1><gtr:line2>Paradise Way</gtr:line2><gtr:line3>Coventry Walsgrave Triangle</gtr:line3><gtr:postCode>CV2 2TX</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8CDDC1A4-41DC-480F-A9C9-580384621FAB"><gtr:id>8CDDC1A4-41DC-480F-A9C9-580384621FAB</gtr:id><gtr:firstName>Wamadeva</gtr:firstName><gtr:surname>Balachandran</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D2F38400-728B-4415-A0B3-0CA8B481B825"><gtr:id>D2F38400-728B-4415-A0B3-0CA8B481B825</gtr:id><gtr:firstName>Ala</gtr:firstName><gtr:surname>Szczepura</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D2138BBC-0B8D-47F3-87A8-2791DF312353"><gtr:id>D2138BBC-0B8D-47F3-87A8-2791DF312353</gtr:id><gtr:firstName>Pam</gtr:firstName><gtr:surname>Sonnenberg</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3A3A48A0-42D3-40F5-AF32-E5A9ED6A57E4"><gtr:id>3A3A48A0-42D3-40F5-AF32-E5A9ED6A57E4</gtr:id><gtr:firstName>Phillip</gtr:firstName><gtr:surname>Hay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/62052C95-B3EC-4B43-97F5-8AE7A4A466D8"><gtr:id>62052C95-B3EC-4B43-97F5-8AE7A4A466D8</gtr:id><gtr:firstName>Jayshree</gtr:firstName><gtr:surname>Dave</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/21E7FD87-BD4F-49D4-B0E0-ED7A0F4F5257"><gtr:id>21E7FD87-BD4F-49D4-B0E0-ED7A0F4F5257</gtr:id><gtr:firstName>Claudia</gtr:firstName><gtr:surname>Estcourt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3E576464-66ED-41CD-933E-872230687E6D"><gtr:id>3E576464-66ED-41CD-933E-872230687E6D</gtr:id><gtr:firstName>Kate</gtr:firstName><gtr:surname>Hone</gtr:surname><gtr:orcidId>0000-0001-5394-8354</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/89048EBE-F920-4367-AED4-F4B6A044E9EA"><gtr:id>89048EBE-F920-4367-AED4-F4B6A044E9EA</gtr:id><gtr:firstName>Syed Tariq</gtr:firstName><gtr:surname>Sadiq</gtr:surname><gtr:orcidId>0000-0002-0608-3818</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D847E0F-0B3B-41B7-A23D-548BC4B1B4A5"><gtr:id>6D847E0F-0B3B-41B7-A23D-548BC4B1B4A5</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Butcher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/873A7353-7EE5-4DB7-AAEA-1D905A24A5DC"><gtr:id>873A7353-7EE5-4DB7-AAEA-1D905A24A5DC</gtr:id><gtr:firstName>George</gtr:firstName><gtr:surname>Griffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/090C961C-7E59-4708-B501-C117570CCCC7"><gtr:id>090C961C-7E59-4708-B501-C117570CCCC7</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:surname>Planche</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1DF2C52F-A2B5-4F6F-A6D3-EDE5392920AA"><gtr:id>1DF2C52F-A2B5-4F6F-A6D3-EDE5392920AA</gtr:id><gtr:firstName>Sanjeev</gtr:firstName><gtr:surname>Krishna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/26741BBA-841E-4B3F-B08D-AFE69842B338"><gtr:id>26741BBA-841E-4B3F-B08D-AFE69842B338</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Ison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E5AC8C88-78B8-4749-9085-77E780D1533C"><gtr:id>E5AC8C88-78B8-4749-9085-77E780D1533C</gtr:id><gtr:firstName>Noel</gtr:firstName><gtr:surname>Gill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/00F0A2DD-1FFA-474B-877D-2007CDA98925"><gtr:id>00F0A2DD-1FFA-474B-877D-2007CDA98925</gtr:id><gtr:firstName>Stephanie</gtr:firstName><gtr:otherNames>Angela</gtr:otherNames><gtr:surname>Chisholm</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9A39A3EE-B0A7-4790-AD60-93E444AE566C"><gtr:id>9A39A3EE-B0A7-4790-AD60-93E444AE566C</gtr:id><gtr:firstName>Jason</gtr:firstName><gtr:surname>Hinds</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E4D768A1-F41C-408C-AE2A-E3944ACC0AC3"><gtr:id>E4D768A1-F41C-408C-AE2A-E3944ACC0AC3</gtr:id><gtr:firstName>Pippa</gtr:firstName><gtr:surname>Oakeshott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FF36E28A-1220-4BF7-B7E0-04D2BB3A2270"><gtr:id>FF36E28A-1220-4BF7-B7E0-04D2BB3A2270</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Lowndes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901608"><gtr:id>AE88D7E6-0D7B-41FB-9E14-E7155AA2A1A8</gtr:id><gtr:title>Enabling and translating advances in diagnostic and communication technologies to reduce the burden of STIs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901608</gtr:grantReference><gtr:abstractText>Sexually transmitted infections (STIs) are a serious health problem in the UK, particularly in young people and the Government have made tackling them an urgent priority. STIs are also becoming increasingly resistant to antibiotics, making treatment much more difficult. Untreated STIs cause serious long term consequences to those affected, such as reduced fertility. One way of improving the situation would be to use better tests that diagnose individuals in clinic, with results in 20 minutes or so, as opposed to sending samples away and waiting a few days. This allows doctors to provide immediate treatment, advice and to get patients to tell their sexual partners to get checked and treated. All this reduces the chances of spreading infection. This new consortium called eSTI2, (electronic self-testing instruments for sexually transmitted infections) aims to bring together recent scientific developments in micro-engineering, molecular biology and telecommunications, working in partnership with biotech companies to help develop new types of rapid tests for STIs. The tests could, for example, allow people to use them like a pregnancy test - ?a self-test? - and link their results to their mobile phones (safely and securely) and then electronically to clinics, so individuals can get treated quickly. This might also allow public health doctors to get a better measure of how much infection exists in the population. An important part of eSTI2 scientists? work will be to turn ?gene chips? in micro-devices (their own and those of biotech companies) into a single test that can detect many different STIs at once. eSTI2 also aims to support getting the best tests introduced into the NHS as quickly as possible. eSTI2 will set up networks of STI clinics and microbiology labs across the UK, to test how well the devices work with real life patients and get the devices properly approved. It will consult a range of people all likely to be affected by the tests, for example patients and doctors, about the best way to use them. It will also try to find the best way to combine the use of mobile phones and rapid STI tests in the community, most effectively.</gtr:abstractText><gtr:technicalSummary>eSTI2 (electronic self testing instruments for sexually transmitted infections) is a multi-disciplinary consortium that aims to reduce the burden of STIs by building translational capacity to develop, improve, evaluate, adopt and facilitate the use of simple to use, rapid, accurate, polymicrobial and affordable point-of-care (PoC) and self-test mobile-phone networked micro-diagnostics. These ?eSTI2 technologies? will provide high-risk populations with easy and immediate access to STI diagnosis and treatment and make STI surveillance comprehensive and responsive. Implementation is currently hindered by: technological bottlenecks; lack of capacity to translate advances into validated commercial products; absence of single tests for multiple STI organisms; and little knowledge about the regulatory constraints, ethical challenges and health impacts of using telecommunications to personalise STI diagnosis and management. eSTI2 uniquely combines academic and industrial expertise to address these challenges through cross-disciplinary translational research and by creating trials capacity. There are 5 workstreams: 
1. Translational microbiology: provides pathogen genomics and microarray expertise to evaluate DNA reporters for detecting multiple STI pathogens and antibiotic resistance markers and to incorporate these onto varied biosensor devices, with industry partners to deliver prototype PoC devices for clinical evaluation. 
2. Microfluidics: will research barriers to developing microsystems and evaluate prototype devices for genital sample processing as a ?front-end? system for novel bio-sensing technologies. 
3. Diagnostic Evaluation: will link the HPA?s network of GUM clinics and associated local microbiological laboratories in England, used for surveillance of HIV/STIs (GUMNet), directly to central microbiology laboratories to create sustainable capacity for clinical trials of novel diagnostics.
4. Public health impact of diagnostic interventions: will extensively assess the regulatory, clinical, governance and health-economic constraints of eSTI2 community testing and develop a wireless-web-based system for managing remote STI diagnosis. It will conduct a community-based proof-of-concept study of eSTI2 deployment in preparation for community-based trials of mobile-interfacing self-testing diagnostics. 
5. Knowledge transfer and Networking: will promote: dissemination of research findings, inform on strategic challenges and sustain collaboration with industry in order to test novel diagnostic devices using the eSTI2 evaluation pipeline. 

Career development in translation infection research will be provided to six interdisciplinary PhD studentships and two Academic Clinical Fellowships. Bidirectional collaboration with industry will provide financial sustainability beyond the 5 years of UKCRC funding. Impact: Significant enhancement in capacity for translational research into novel diagnostics aimed at improving treatment, reducing STI transmission and improving sexual health of high-risk groups.</gtr:technicalSummary><gtr:fund><gtr:end>2017-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3934917</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI clinical network</gtr:description><gtr:id>733231A0-E52D-4C08-A6C7-38A70E8B15FD</gtr:id><gtr:impact>Patient recruitment commenced in May 2012 initially at the Courtyard clinicand later in 2014 at the Roehampton clinic, the Burrell street clinic and at the Kingsway centre in Stevenage. Orsett Hospital, West Middlesex Hospital and Northern Devon NHS Trust are currently in the set up stage with feasibility analyses ongoing. Southend-on-sea has also expressed an interest to join the stuidy.</gtr:impact><gtr:outcomeId>5463b6aa46ed35.07414674-1</gtr:outcomeId><gtr:partnerContribution>Patient recruitment, Sample collection, Data collection</gtr:partnerContribution><gtr:piContribution>Site set up
R&amp;amp;D approvals
Site training
Site monitoring
Patient recruitment, Sample collection, Data collection
Sample preservation and transport</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cepheid</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Lambeth College Chlamydia Testing</gtr:description><gtr:id>98D49047-A0B0-4103-BB47-FE7727C03C69</gtr:id><gtr:impact>Publication: Sharman N1, Sri T1, Chow C2, Pond MJ2, Oakeshott P1, Planche T3, Sadiq ST4.Chlamydia testing: Reaching high-risk sexually active young people in the community. Int J STD AIDS. Epub 2015 Apr 29. 2016 Jan;27(1):78-9.</gtr:impact><gtr:outcomeId>5463b9c4846da4.22295649-3</gtr:outcomeId><gtr:partnerContribution>Lambeth College provided access to the college and students.
St George's NHS Trust provided follow up to students who were diagnosed positive for Chlamydia.
Cepheid provided a testing platform and 50 cartridges.</gtr:partnerContribution><gtr:piContribution>Planned and implemented a day of opportunistic Chlamydia testing in an inner London further education college</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Knight Scientific Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Knight Scientific</gtr:description><gtr:id>9BC92D50-6781-4F15-A6E0-3E4C4352C1F6</gtr:id><gtr:impact>Agreement in development</gtr:impact><gtr:outcomeId>qZMt2MdKowa-1</gtr:outcomeId><gtr:partnerContribution>Entry to the eSTI2 diagnostic pipeline</gtr:partnerContribution><gtr:piContribution>Discussions on the potential for evaluating the rapid platform for inflammation</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>West Middlesex University Hospital NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI clinical network</gtr:description><gtr:id>72A71B82-F35D-44D2-AE93-7B7A8824683F</gtr:id><gtr:impact>Patient recruitment commenced in May 2012 initially at the Courtyard clinicand later in 2014 at the Roehampton clinic, the Burrell street clinic and at the Kingsway centre in Stevenage. Orsett Hospital, West Middlesex Hospital and Northern Devon NHS Trust are currently in the set up stage with feasibility analyses ongoing. Southend-on-sea has also expressed an interest to join the stuidy.</gtr:impact><gtr:outcomeId>5463b6aa46ed35.07414674-6</gtr:outcomeId><gtr:partnerContribution>Patient recruitment, Sample collection, Data collection</gtr:partnerContribution><gtr:piContribution>Site set up
R&amp;amp;D approvals
Site training
Site monitoring
Patient recruitment, Sample collection, Data collection
Sample preservation and transport</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Becton, Dickinson and Company (BD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Becton Dickinson (BD)</gtr:description><gtr:id>2A8600DF-F183-43F0-A3E0-CEAFB120F968</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>58b93fc7ef1532.92751884-1</gtr:outcomeId><gtr:partnerContribution>-</gtr:partnerContribution><gtr:piContribution>Advisory board membership</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Hallamshire Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chlamydia Sexual Behaviour and Near-Patient Testing Network</gtr:description><gtr:id>CFEF110A-A889-42A0-B049-E3E07C4B2C74</gtr:id><gtr:impact>1. Webtool: http://www.poctic.uk.net

2. User guide for webtool: Point-of-Care Tests for Chlamydia (POCTiC) Web-Tool: A tool for assessing the public health impact of introducing point-of-care testing for chlamydia

3. Abstracts and posters at UK Public health conference (Glasgow, November 2014); PHE Applied Epidemiology conference (Warwick, March 2015); BASHH (June 2015); ISSTDR (Brisbane, September 2015) 

4. Data collection complete for study: Sexual behaviour in the time period between being tested for 
Chlamydia trachomatis and receiving the test result and treatment.</gtr:impact><gtr:outcomeId>5463b1571254b6.71485650-4</gtr:outcomeId><gtr:partnerContribution>Sites provided data for sexual behaviour model.</gtr:partnerContribution><gtr:piContribution>Set up and liaised with sites to investigate the sexual behaviour in the time period between being tested for Chlamydia trachomatis and receiving the test result and treatment</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>SpeedDX Pty</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>SpeedDx</gtr:description><gtr:id>5B32D83A-FDF5-4B25-8641-7E35B00C4E45</gtr:id><gtr:impact>No outcomes yet</gtr:impact><gtr:outcomeId>5643266c85b917.50609653-1</gtr:outcomeId><gtr:partnerContribution>SpeedDx is accessing the eSTI2 diagnostic pipeline</gtr:partnerContribution><gtr:piContribution>Planning and implementation of evaluation of Mycoplasma genitalium assay. Study ongoing.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lloyds Pharmacy</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lloyds Pharmacy</gtr:description><gtr:id>2FDAF9E0-942E-4CB2-AB98-93D58CAA9620</gtr:id><gtr:impact>Barriers to successful pharmacy provision of prepacked antibiotics identified</gtr:impact><gtr:outcomeId>DT1GhaLjNdZ-1</gtr:outcomeId><gtr:partnerContribution>Lloyds Pharmacy are happy to be associated with the eSTI2 programme, with seven of thirty pharmacies participating in the Chlamydia Online Clinical Care Pathway exploratory study.</gtr:partnerContribution><gtr:piContribution>Lloyds Pharmacy are the preferred provider of prescription services within the community trials for STI point of care diagnostics</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>QMUL</gtr:description><gtr:id>91134881-26FB-4D07-9045-2F69763C7C8C</gtr:id><gtr:impact>On-going collaboration</gtr:impact><gtr:outcomeId>nzpewPoUj4B-1</gtr:outcomeId><gtr:partnerContribution>Leading on the development of community trials</gtr:partnerContribution><gtr:piContribution>Joint development of Community Trials for eSTI2 Consortium</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Atlas Genetics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Atlas Genetics</gtr:description><gtr:id>362D4C39-216F-46E8-BFEA-A7023B7E655E</gtr:id><gtr:impact>Completion of 2 studies and in final stages of a third evaluation. Data from these evaluations will be used by Atlas Genetics as part of their CE-marking submission.
There have been 2 successful grant applications in collaboration with Atlas Genetics: i.) NIHR i4i grant to develop a 4-pathogen test with antimicrobial resistance detection for Neisseria gonorrhoeae and Mycoplasma genitalium (Tariq Sadiq Chief Investigator) ii.) Innovate UK SBRI grant, awarded to Atlas Genetics but written in close collaboration with eSTI2 members (lead: Tariq Sadiq), with &amp;gt;&amp;pound;100,000 of award sub-contracted to SGUL.</gtr:impact><gtr:outcomeId>ejmbkrQLuJK-1</gtr:outcomeId><gtr:partnerContribution>Atlas Genetics has accessed the eSTI2 diagnostic pipeline.</gtr:partnerContribution><gtr:piContribution>3 evaluations have been conducted with Atlas Genetics: one for assay development (residual samples for males, patient-consented samples for females); one inter-site variability evaluation; one performance evaluation using patient-consented samples (near completion).
We have 2 successful grant applications with Atlas Genetics</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mologic</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mologic</gtr:description><gtr:id>4057116F-57B7-4C92-B251-6F205E524179</gtr:id><gtr:impact>Product development has progress to next stage from evaluation undertaken.
Potential for further evaluations for other infectious diseases</gtr:impact><gtr:outcomeId>58b942de1da8c6.87655116-1</gtr:outcomeId><gtr:partnerContribution>Tested samples provided</gtr:partnerContribution><gtr:piContribution>Planned and implemented, monitored and analysed data for Mologic BV assay early stage evaluation.
Provided clinical samples</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's and St Thomas' NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI clinical network</gtr:description><gtr:id>6D6039B4-07F5-4783-AD08-7C4E5DAC968D</gtr:id><gtr:impact>Patient recruitment commenced in May 2012 initially at the Courtyard clinicand later in 2014 at the Roehampton clinic, the Burrell street clinic and at the Kingsway centre in Stevenage. Orsett Hospital, West Middlesex Hospital and Northern Devon NHS Trust are currently in the set up stage with feasibility analyses ongoing. Southend-on-sea has also expressed an interest to join the stuidy.</gtr:impact><gtr:outcomeId>5463b6aa46ed35.07414674-3</gtr:outcomeId><gtr:partnerContribution>Patient recruitment, Sample collection, Data collection</gtr:partnerContribution><gtr:piContribution>Site set up
R&amp;amp;D approvals
Site training
Site monitoring
Patient recruitment, Sample collection, Data collection
Sample preservation and transport</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brunel Institute for Bioengineering (BIB)</gtr:department><gtr:description>Brunel University Microfluidics / HCI Development</gtr:description><gtr:id>8B294C04-640F-4580-AC8A-2A45CF649A5E</gtr:id><gtr:impact>The final Grant Output report submitted to the MRC 2008.

Please see publications list</gtr:impact><gtr:outcomeId>A4A998728C7-1</gtr:outcomeId><gtr:partnerContribution>Participated actively in developing the Consortium Strategy and is a major partner in the full Consortium Grant application. Technologies Workshop. 16th July 2008. St George's University of London. Attended by 19 delegates Topics included:- Microfluidic research questions centered on the challenges around extraction of DNA, isothermal amplification and real time detection systems. Wireless Technologies discussions centered around: ? the interactive nature of devices, linking of wireless-processes within social networking; ? how the devices will self power, theoretical molecular signal processing, signal detection, processing and using information and data security. ? Planning the integration of existing off-the shelf POC systems and testing them in various clinical settings was a proposed area of research. Considerable time was spent discussing IT governance and, data encryption and security. A detailed discussion took place on the management structure of the consortium, the importance of microbiological leadership and capacity for microbiological training arising out of the eSTI2/UKCRC initiative. The Centre for Infections has participated actively in developing the Consortium Strategy and is a major partner in the full Consortium Grant application</gtr:partnerContribution><gtr:piContribution>Ongoing interaction in the eSTI2 consortium to deliver project objectives. The key elects are in the development of microfluidc platform to enable adequate sample processing for rapid NAAT detection systems. Equally the development of software (mobile and web-based to support the development of clinical care pathways. (2011-2013)

We initially have worked in this collaboration in developing our Consortium Strategy Development Grant in 2008. Consortium Seminar, 20th May 2008. Held at St George's, University of London. The main purpose of this seminar was to invite potential consortium partners so as to present the vision of the UKCRC and eSTI2 consortium and to elicit interest, support, contribution and agreement to participate from collaborators across the different disciplines. One whole day seminar, comprising of a morning session explaining the proposed structure of the Consortium, timelines of development and initial plan for taking the work forward. Invitees from different disciplines including Epidemiology, Clinical Medicine, Engineering, Microfluidics, Wireless and Industry (including those from diagnostics, management and biotech) were invited to the seminar. 40 delegates attended the seminar and Workshops.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aquarius Population Health Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Aquarius Population Health</gtr:description><gtr:id>88963C0F-8616-44E4-A696-F9F2B6939D0A</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56c3392c99e855.82363566-1</gtr:outcomeId><gtr:partnerContribution>Protocol development, modelling and cost-effectiveness analyses</gtr:partnerContribution><gtr:piContribution>Modelling the impact and cost-effectiveness of STI POC devices.
Study idea, scoping document.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Northern Devon Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI clinical network</gtr:description><gtr:id>C22508EA-0D52-4B54-9CE9-887D3893207B</gtr:id><gtr:impact>Patient recruitment commenced in May 2012 initially at the Courtyard clinicand later in 2014 at the Roehampton clinic, the Burrell street clinic and at the Kingsway centre in Stevenage. Orsett Hospital, West Middlesex Hospital and Northern Devon NHS Trust are currently in the set up stage with feasibility analyses ongoing. Southend-on-sea has also expressed an interest to join the stuidy.</gtr:impact><gtr:outcomeId>5463b6aa46ed35.07414674-5</gtr:outcomeId><gtr:partnerContribution>Patient recruitment, Sample collection, Data collection</gtr:partnerContribution><gtr:piContribution>Site set up
R&amp;amp;D approvals
Site training
Site monitoring
Patient recruitment, Sample collection, Data collection
Sample preservation and transport</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WHO collaboration for technical specifications on point-to-point care tests for STIs.</gtr:description><gtr:id>4BFFC2D1-D2A6-4747-833C-547CC9C403A5</gtr:id><gtr:impact>Technical specifications for industry development of point-of-care tests for STIs.</gtr:impact><gtr:outcomeId>5464b6bac23648.78907665-1</gtr:outcomeId><gtr:partnerContribution>Organised and brought together world specialists</gtr:partnerContribution><gtr:piContribution>Took part in 3-day consultation at the WHO's 1st technical consultation on point-to-point care tests for STIs to develop technical specifications for industry development of point-of-care tests for STIs.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Gene Technology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Oxford Gene Technology - STI Polymicrobial Array</gtr:description><gtr:id>3F74F7AC-912D-4BC1-BBD1-3B5942342F5E</gtr:id><gtr:impact>Development and Validation of a Microarray Enabling Simultaneous Detection of MultipleSexually Transmitted Infections. Division of Cellular and Molecular Medicine, St George's, University of London. Oxford Gene Technology, Begbroke Science Park, Yarnton, Oxford MRC Biostatistics Unit, Institute of Public Health, Cambridge Department of Genitourinary Medicine, St George's Healthcare NHS Trust. Publication - In preparation of the above Title</gtr:impact><gtr:outcomeId>8501AB3BA4A-1</gtr:outcomeId><gtr:partnerContribution>OGT have provided intellectual input into the design of our polymicrobial STI array and supportive to the subsequent bid for a full Consortium Grant. OGT have participated in workshops and seminars in developing the strategy for the Consortium.</gtr:partnerContribution><gtr:piContribution>We have clinically evaluated the utility of a 28 organism -polymicrobial STI array for diagnosing multiple sexually transmitted infections. The array was designed in collaboration with Oxford Gene Technology.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hertfordshire Community NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>AE424303-5BB8-423F-BD9A-FCFCAE9D6EBB</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-6</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Barts Health NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Ambrose King Centre</gtr:department><gtr:description>Chlamydia Sexual Behaviour and Near-Patient Testing Network</gtr:description><gtr:id>BA41AB85-C537-4E0A-8705-C78E2A3351E9</gtr:id><gtr:impact>1. Webtool: http://www.poctic.uk.net

2. User guide for webtool: Point-of-Care Tests for Chlamydia (POCTiC) Web-Tool: A tool for assessing the public health impact of introducing point-of-care testing for chlamydia

3. Abstracts and posters at UK Public health conference (Glasgow, November 2014); PHE Applied Epidemiology conference (Warwick, March 2015); BASHH (June 2015); ISSTDR (Brisbane, September 2015) 

4. Data collection complete for study: Sexual behaviour in the time period between being tested for 
Chlamydia trachomatis and receiving the test result and treatment.</gtr:impact><gtr:outcomeId>5463b1571254b6.71485650-5</gtr:outcomeId><gtr:partnerContribution>Sites provided data for sexual behaviour model.</gtr:partnerContribution><gtr:piContribution>Set up and liaised with sites to investigate the sexual behaviour in the time period between being tested for Chlamydia trachomatis and receiving the test result and treatment</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>North East London NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>1C15BD6C-C82C-48BE-A735-3DD797F63039</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-7</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>3QBD</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>3QBD</gtr:description><gtr:id>F4C440FD-A324-4783-B7AB-E2E01A074C33</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>NiVyUVsuX7V-1</gtr:outcomeId><gtr:partnerContribution>Work may lead to further collaborative work via the eSTI2 diagnostic pipeline</gtr:partnerContribution><gtr:piContribution>eSTI2 supported the evaluation of the VG sense rapid test for bacterial vaginosis.

Update: Collected 142 residual female vulvo-vaginal swabs and the corresponding gram stain slide</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dorset County Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>7E19C66B-C5FC-45C1-822F-8A68518BEF04</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-5</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Axxin</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Axxin</gtr:description><gtr:id>F68F5D2E-C1F2-4CFD-989B-195E9BC2FEE1</gtr:id><gtr:impact>The collaboration have helped in the development of the assays for the PoC instrument developed by Brunel University</gtr:impact><gtr:outcomeId>56962b01d78bc0.57131795-1</gtr:outcomeId><gtr:partnerContribution>Axxin have loaned Brunel University the Axxin ISO T16 Platform for over 2 years</gtr:partnerContribution><gtr:piContribution>Brunel University have thoroughly tested the ISO T16 isothermal amplification platform and provided feedback to the company on usability and operation</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIHR Diagnostic Evidence Co-operatve</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DEC</gtr:description><gtr:id>235AEDE8-D63D-4580-927F-29B54D8D29C2</gtr:id><gtr:impact>DDW conference</gtr:impact><gtr:outcomeId>58b94130c9bf64.59458297-1</gtr:outcomeId><gtr:partnerContribution>Knowledge for the Atlas Genetics diagnostic. Imperial DEC has presented at the Brunel Diagnostics for the Developing world conference supported by eSTI2</gtr:partnerContribution><gtr:piContribution>Attended DEC meetings in Newcastle and London, worked with the Oxford DEC on developing novel diagnostic with Atlas Genetics</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Solent NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>D08B0E3C-1327-42F5-8C94-B65244901ED7</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-2</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Epistem</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Epistem</gtr:description><gtr:id>C543E6FB-5659-4EF1-BD8D-F9F846DC1153</gtr:id><gtr:impact>Research proposal to NIHR initiated</gtr:impact><gtr:outcomeId>N88L4C7PtMA-1</gtr:outcomeId><gtr:partnerContribution>Joint research proposal</gtr:partnerContribution><gtr:piContribution>Development of a research proposal and discussion on translating probes to their diagnostic platform</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bradford Teaching Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>0D45F985-2B6B-4C42-AEA6-DCCC76352444</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-1</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Moorlodge Biotech Ventures</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Moorlodge Biotech Ventures (now Healthcare Diagnostics (HCD))</gtr:description><gtr:id>5A70EA80-37D5-42E5-B747-F87FD4F07AA0</gtr:id><gtr:impact>Demonstrated the commitment made in the proposal to translate bio markers to companies. Work is ongoing to move to the next phase transferring Healthcare Diagnostics into the Diagnostic Evaluation workstream, to do an initial performance evaluation using residual samples.</gtr:impact><gtr:outcomeId>aZZGK1swgiD-1</gtr:outcomeId><gtr:partnerContribution>HCD will access the eSTI2 diagnostic pipeline.</gtr:partnerContribution><gtr:piContribution>This is a translational collaboration. eSTI2 has transferred probes for detection of sexually transmitted diseases to HCD for incorporation onto their point of care diagnostic platform.

Update: A total of 431 residual samples have been collected. Visits have been made to HCD to help with troubleshooting. Testing of the device is ongoing.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BJS Biotechnologies Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BJS Biotechnologies</gtr:description><gtr:id>668A9C6A-D860-47E7-B486-B707B01CE510</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>56962bc6067287.51715565-1</gtr:outcomeId><gtr:partnerContribution>Brunel and BJS have collaborated in writing 2 proposals for rapid near patient Sepsis testing</gtr:partnerContribution><gtr:piContribution>Brunel and BJS have collaborated in writing 2 proposals for rapid near patient Sepsis testing</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>CROMSOURCE</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>CromSource (formally known as Pleiad Inc)</gtr:description><gtr:id>22904176-67CE-46CE-A740-99A6529A3F62</gtr:id><gtr:impact>Development of the ethical and regulatory requirements. These have now been successfully approved for performing diagnostic evaluations.</gtr:impact><gtr:outcomeId>dgLPHXx4mt3-1</gtr:outcomeId><gtr:partnerContribution>Crom Source (formerly Pleiad inc) have assisted eSTI2 in developing the ethical and regulatory framework for the diagnostic evaluation pipeline being created in the project.</gtr:partnerContribution><gtr:piContribution>-</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>epiGenesys Ltd</gtr:department><gtr:description>Epigenyses - Collaborative development of a web-based clinic care pathway for managing Chlamydia trachoma tis infection</gtr:description><gtr:id>AEEAA6F0-296A-4B1B-8366-1CDECDECA6D2</gtr:id><gtr:impact>The first pilot exploratory study was completed in March 2015and presented at ISSTDR 2015.</gtr:impact><gtr:outcomeId>546387a5be5334.57390502-1</gtr:outcomeId><gtr:partnerContribution>They have developed the software in from the specification and wireframe developed by the team.</gtr:partnerContribution><gtr:piContribution>The workstream led by Dr Claudia Estcourt at QMUL, Dr Pam Sonnenberg at UCL, Dr Kate Hone at Brunel University, Professor Ala Szczepura at Warwick University and Dr Tariq Sadiq at St George's University have developed the Chlamydia Online Clinical Care Pathway system software in collaboration with the software company Epigenesys.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Reading</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Microcapillary microfluidic detection assays</gtr:description><gtr:id>237DAAFC-9DDC-4C3D-806A-8ACAD4B2C7EC</gtr:id><gtr:impact>Currently ongoing. Funding for this project has been sought by Loughborough university</gtr:impact><gtr:outcomeId>5463b98f4ece92.14587805-2</gtr:outcomeId><gtr:partnerContribution>Plan for multiplex detection of cytokines on a rapid fluoropolymer microcapillary device using initially a flurophore and later on colourimetric methods to enable mobile phone reading</gtr:partnerContribution><gtr:piContribution>Sample characterisation
Plan for comparison of cytokine detection by standard methods with a fluoropolymer microcapillary device
Clinical study protocol development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leicester Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chlamydia Sexual Behaviour and Near-Patient Testing Network</gtr:description><gtr:id>8367C295-767C-4616-9B16-728C6EE276D9</gtr:id><gtr:impact>1. Webtool: http://www.poctic.uk.net

2. User guide for webtool: Point-of-Care Tests for Chlamydia (POCTiC) Web-Tool: A tool for assessing the public health impact of introducing point-of-care testing for chlamydia

3. Abstracts and posters at UK Public health conference (Glasgow, November 2014); PHE Applied Epidemiology conference (Warwick, March 2015); BASHH (June 2015); ISSTDR (Brisbane, September 2015) 

4. Data collection complete for study: Sexual behaviour in the time period between being tested for 
Chlamydia trachomatis and receiving the test result and treatment.</gtr:impact><gtr:outcomeId>5463b1571254b6.71485650-2</gtr:outcomeId><gtr:partnerContribution>Sites provided data for sexual behaviour model.</gtr:partnerContribution><gtr:piContribution>Set up and liaised with sites to investigate the sexual behaviour in the time period between being tested for Chlamydia trachomatis and receiving the test result and treatment</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UCL - Epidemiolgy and Public Health Workstreams</gtr:description><gtr:id>7C574FD1-02C3-4951-8158-4EBFBAC2908D</gtr:id><gtr:impact>MRC Report Submitted 2008

See publications list</gtr:impact><gtr:outcomeId>74AABFF39AB-1</gtr:outcomeId><gtr:partnerContribution>Development of clinical care pathways for eSTI2.
Epidemiology/Clinical Workshop 18th June 2008. Held at St George's University of London. Attended by 12 delegates from SGUL, UCL, University of Sussex Key areas that were discussed included: 1. The direction of the Consortium 2. Distillation of a diverse number of clinical and epidemiological research proposals that would be needed to underpin the work of the Consortium. 3. The structure of the consortium, leadership and institutional support were also discussed in detail.</gtr:partnerContribution><gtr:piContribution>Contributing to the development of clinical care pathways. 
Consortium Seminar and various workshops.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Qiagen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Qiagen</gtr:description><gtr:id>690B89E7-D202-4AE0-9400-12ADD7CC324B</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56c339d645a923.71247526-1</gtr:outcomeId><gtr:partnerContribution>Loan of instrumentation</gtr:partnerContribution><gtr:piContribution>Qiagen Artus Trichomonas vaginalis test evaluation. Qiagen are developing a TV diagnostic test, which they have asked us to evaluate once it has received CE-marking.
eSTI2 diagnostic pipeline, protocol development, ethical approval</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Quidel</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Quidel LTF technology for BV</gtr:description><gtr:id>9F6C4841-D82B-4B5F-B062-A8A853DB64F7</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>5463b2c5a353e7.47185180-1</gtr:outcomeId><gtr:partnerContribution>Quidel will access the eSTI2 diagnostic pipeline.</gtr:partnerContribution><gtr:piContribution>Provided linkages to UK services for planned evaluations.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Central London Community Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>0544A61A-5AC7-4AC5-BBB3-26BFED590187</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-8</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital NHS Foundation Trust (NCH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Kings College London</gtr:description><gtr:id>F1F47DC5-5E1E-4A63-8DC1-50E828487651</gtr:id><gtr:impact>Definition of ethical protocols. 
See publications - evaluation of microscopy free pathways presented at Vienna ISSTDR 2013</gtr:impact><gtr:outcomeId>YX1F4PNjqCh-1</gtr:outcomeId><gtr:partnerContribution>Collection of residual STI2 samples and collaboration within the eSTI2 programme of work</gtr:partnerContribution><gtr:piContribution>Brining in KCL into the network of clinics to perform diagnostic and clinical evaluations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>North East London NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI clinical network</gtr:description><gtr:id>4985E6A1-D8E0-4883-978B-D6DBF3DA9D4E</gtr:id><gtr:impact>Patient recruitment commenced in May 2012 initially at the Courtyard clinicand later in 2014 at the Roehampton clinic, the Burrell street clinic and at the Kingsway centre in Stevenage. Orsett Hospital, West Middlesex Hospital and Northern Devon NHS Trust are currently in the set up stage with feasibility analyses ongoing. Southend-on-sea has also expressed an interest to join the stuidy.</gtr:impact><gtr:outcomeId>5463b6aa46ed35.07414674-4</gtr:outcomeId><gtr:partnerContribution>Patient recruitment, Sample collection, Data collection</gtr:partnerContribution><gtr:piContribution>Site set up
R&amp;amp;D approvals
Site training
Site monitoring
Patient recruitment, Sample collection, Data collection
Sample preservation and transport</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Alere</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Alere</gtr:description><gtr:id>676131E8-BD90-4BA5-8460-AA4A427C0A1C</gtr:id><gtr:impact>Evaluation of a microscopy free pathway which incorporated the Alere lateral flow test for bacterial vaginosis. Presented at the ISSTDR in Vienna 2013. Publication in preparation.
Successful grant application to the NIHR RfPB with Pippa Oakeshott as lead application, and Tariq Sadiq as co-applicant. Alere will provide 1000 tests for the study.</gtr:impact><gtr:outcomeId>WHCcQRZADc9-1</gtr:outcomeId><gtr:partnerContribution>Contribution at seminars and presentations. 
Contributions of test kits for in clinic evaluations of rapid flow tests.</gtr:partnerContribution><gtr:piContribution>Discussions with Alere for clinical trials within the eSTI2 pipeline for their identibac system. Transfer of multiple DNA probe sets (IP held at SGUL) for incorporation on to he CLONDIAG system. 

Evaluation of a lateral floe rapid test for bacterial vaginosis</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ministry of Public Health</gtr:collaboratingOrganisation><gtr:country>Lebanon, Lebanese Republic</gtr:country><gtr:description>Ministry of Public Health - Ecuador</gtr:description><gtr:id>69D59923-A05B-4F62-9F1C-4D096292DA31</gtr:id><gtr:impact>Grant applications</gtr:impact><gtr:outcomeId>58b93d23cd7024.68575668-1</gtr:outcomeId><gtr:partnerContribution>Writing research proposals for development of new diagnostics and implementation in resource poor settings</gtr:partnerContribution><gtr:piContribution>Writing research proposals for development of new diagnostics and implementation in resource poor settings</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>9EB18F18-7A83-494E-B1D0-3CB16E1213E7</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-9</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>QuantuMDx Group Limited</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>QuantumDx</gtr:description><gtr:id>76877341-0DA4-4848-8859-722276145200</gtr:id><gtr:impact>This will enable eSTI2 to exercise the diagnostic evaluation protocols it is developing as part of the translational research.

Two grants enabled: Nanomal and TSB grant for TB</gtr:impact><gtr:outcomeId>gEqWPUnDEP6-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with QuantumDx enables eSTI2 to meet its research objectives</gtr:partnerContribution><gtr:piContribution>This is an ongoing relationship to transfer genetic markers from eSTI2 to QuantumDx. Residual STI patient samples will then be used to evaluate their sensor technology.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chlamydia Sexual Behaviour and Near-Patient Testing Network</gtr:description><gtr:id>4F4B87A2-6336-47CF-9E3D-2EB37AAB190D</gtr:id><gtr:impact>1. Webtool: http://www.poctic.uk.net

2. User guide for webtool: Point-of-Care Tests for Chlamydia (POCTiC) Web-Tool: A tool for assessing the public health impact of introducing point-of-care testing for chlamydia

3. Abstracts and posters at UK Public health conference (Glasgow, November 2014); PHE Applied Epidemiology conference (Warwick, March 2015); BASHH (June 2015); ISSTDR (Brisbane, September 2015) 

4. Data collection complete for study: Sexual behaviour in the time period between being tested for 
Chlamydia trachomatis and receiving the test result and treatment.</gtr:impact><gtr:outcomeId>5463b1571254b6.71485650-3</gtr:outcomeId><gtr:partnerContribution>Sites provided data for sexual behaviour model.</gtr:partnerContribution><gtr:piContribution>Set up and liaised with sites to investigate the sexual behaviour in the time period between being tested for Chlamydia trachomatis and receiving the test result and treatment</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI metabolomics</gtr:description><gtr:id>ED6F51F4-8314-4A26-88FA-2AD119582798</gtr:id><gtr:impact>Sample preparation is currently ongoing with preliminary NMR spectrometry optimisation experiments planned to start imminently</gtr:impact><gtr:outcomeId>5463b16dbe4735.58479317-1</gtr:outcomeId><gtr:partnerContribution>Sample preparation protocol for NMR spectrometry analysis
NMR spectra data analysis</gtr:partnerContribution><gtr:piContribution>Vaginal swab elute preparation for NMR spectrometry
Performing NMR spectroscopy on the prepared samples at UCL premises
NMR spectra data analysis plan</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>TwistDx</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TwistDx</gtr:description><gtr:id>D06ED226-96F2-46E9-99E4-84C7E9A67640</gtr:id><gtr:impact>Peer-review publication in preparation. 
Conference abstracts</gtr:impact><gtr:outcomeId>bgZxVXuZxGp-1</gtr:outcomeId><gtr:partnerContribution>TwistDx have accessed the eSTI2 diagnostic evaluation pipeline.
TwistDx provided consumables and funds to reimburse sites and planning/implementation time incurred. TwistDx have provided 200 CT assays for development of the eSTI2 point of care platform</gtr:partnerContribution><gtr:piContribution>Supply of residual STI patient samples for testing of their Chlamydia assay. Four evaluations have taken place (1 using residual samples, 3 using patient-consented samples) to enable assay development.
Developed robust protocols, planned logistics and successfully implemented within commercial timelines: 1) TwistDX PCE1 residual sample study (100 samples) (St Georges Courtyard Clinic; 2)TwistDx PCE 2 Swab selection study - Clinics: St George's, King's and Dorset - 69 patients recruited 3) TwistDx PCE 3 Background signal determination - Clinics: St George's, Solent and Bradford - 840 patients recruited 4) PCE 3.1 Impact of size exclusion column.
Twist and Brunel University have submitted a Horizon 2020 funding application on paper microfluiidcs</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Microbial community profiling in the POPI study</gtr:description><gtr:id>E47CDE20-4F14-4FFE-8D77-485F0BA7561C</gtr:id><gtr:impact>Funding for the metagenomic work is being sought</gtr:impact><gtr:outcomeId>5463baa41fc608.02467694-2</gtr:outcomeId><gtr:partnerContribution>Grant proposal
Contribution of samples from the POPI study</gtr:partnerContribution><gtr:piContribution>Sample preparation protocol
Metagenomic sequencing protocol
Data analysis plan</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Safeguard Biosystems</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Safeguard</gtr:description><gtr:id>2683C80A-CEF3-4CDC-B1EB-A8A251985909</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>gwV2379fiKs-1</gtr:outcomeId><gtr:partnerContribution>None to date</gtr:partnerContribution><gtr:piContribution>Discussion on the provision of probes for their array based multi-pathogen diagnostic tool</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Information Systems, Computing and Mathematics</gtr:department><gtr:description>Brunel University Microfluidics / HCI Development</gtr:description><gtr:id>D52FFF70-5227-46CB-9A5E-3455974EC979</gtr:id><gtr:impact>The final Grant Output report submitted to the MRC 2008.

Please see publications list</gtr:impact><gtr:outcomeId>A4A998728C7-2</gtr:outcomeId><gtr:partnerContribution>Participated actively in developing the Consortium Strategy and is a major partner in the full Consortium Grant application. Technologies Workshop. 16th July 2008. St George's University of London. Attended by 19 delegates Topics included:- Microfluidic research questions centered on the challenges around extraction of DNA, isothermal amplification and real time detection systems. Wireless Technologies discussions centered around: ? the interactive nature of devices, linking of wireless-processes within social networking; ? how the devices will self power, theoretical molecular signal processing, signal detection, processing and using information and data security. ? Planning the integration of existing off-the shelf POC systems and testing them in various clinical settings was a proposed area of research. Considerable time was spent discussing IT governance and, data encryption and security. A detailed discussion took place on the management structure of the consortium, the importance of microbiological leadership and capacity for microbiological training arising out of the eSTI2/UKCRC initiative. The Centre for Infections has participated actively in developing the Consortium Strategy and is a major partner in the full Consortium Grant application</gtr:partnerContribution><gtr:piContribution>Ongoing interaction in the eSTI2 consortium to deliver project objectives. The key elects are in the development of microfluidc platform to enable adequate sample processing for rapid NAAT detection systems. Equally the development of software (mobile and web-based to support the development of clinical care pathways. (2011-2013)

We initially have worked in this collaboration in developing our Consortium Strategy Development Grant in 2008. Consortium Seminar, 20th May 2008. Held at St George's, University of London. The main purpose of this seminar was to invite potential consortium partners so as to present the vision of the UKCRC and eSTI2 consortium and to elicit interest, support, contribution and agreement to participate from collaborators across the different disciplines. One whole day seminar, comprising of a morning session explaining the proposed structure of the Consortium, timelines of development and initial plan for taking the work forward. Invitees from different disciplines including Epidemiology, Clinical Medicine, Engineering, Microfluidics, Wireless and Industry (including those from diagnostics, management and biotech) were invited to the seminar. 40 delegates attended the seminar and Workshops.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's NHS Trust, London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lambeth College Chlamydia Testing</gtr:description><gtr:id>0485371D-889F-4EA8-B915-F4005F7D4F24</gtr:id><gtr:impact>Publication: Sharman N1, Sri T1, Chow C2, Pond MJ2, Oakeshott P1, Planche T3, Sadiq ST4.Chlamydia testing: Reaching high-risk sexually active young people in the community. Int J STD AIDS. Epub 2015 Apr 29. 2016 Jan;27(1):78-9.</gtr:impact><gtr:outcomeId>5463b9c4846da4.22295649-2</gtr:outcomeId><gtr:partnerContribution>Lambeth College provided access to the college and students.
St George's NHS Trust provided follow up to students who were diagnosed positive for Chlamydia.
Cepheid provided a testing platform and 50 cartridges.</gtr:partnerContribution><gtr:piContribution>Planned and implemented a day of opportunistic Chlamydia testing in an inner London further education college</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's NHS Trust, London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>3F72A5F9-0099-4B62-8089-A1FF24D49290</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-4</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre of Infectious Disease Surveillance and Control</gtr:department><gtr:description>Health Protection Agency -Surveillance and Diagnostic Evaluation</gtr:description><gtr:id>3E5FB055-3061-4237-91DB-E5EBF51BA48F</gtr:id><gtr:impact>Development of a distinct strategy for Translational Infection Research. The final Grant Output report submitted to the MRC 2008.
Please see publications and grants</gtr:impact><gtr:outcomeId>2CD20F69B24-1</gtr:outcomeId><gtr:partnerContribution>The Centre for Infections has participated actively in developing the Consortium Strategy and is a major partner in the full Consortium Grant application</gtr:partnerContribution><gtr:piContribution>We have worked in this collaboration in developing our Consortium strategy.
Involvement (Scientific Steering Committee) with PHE Innovate UK SBRI grant (Development of a tool for assessment of the impact of introduction of point-of-care tests for STIs), with 2 main projects: i.) Development of a user-friendly webtool to assess the cost and epidemiological impact of implementing point of care tests for chlamydia at the local level; ii.) Investigating sexual behaviour in the time period between being tested for chlamydia and receiving test result and treatment.
Systematic review of rectal Chlamydia.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>iBOSSolutions Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>iBOSSolutions</gtr:description><gtr:id>49E69D92-88E2-4E82-BB5B-C631F5513205</gtr:id><gtr:impact>Definition of the system architecture requirements.
Disciplines involved: Computer science, human computer interaction, medical diagnostics</gtr:impact><gtr:outcomeId>sJD2AeHNSLx-1</gtr:outcomeId><gtr:partnerContribution>IBOSS are helping with defining the security protocols and system architecture requirements for a series of pilot trials of the eSTI2 diagnostic pathway</gtr:partnerContribution><gtr:piContribution>eSTI2 and iBOS are partnering to translate the remote clinical pathway developed within eSTI2 to the commercial sphere.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hertfordshire Community NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 PolySTI clinical network</gtr:description><gtr:id>61C027A6-9EDA-4751-8A53-E67495EAF6B2</gtr:id><gtr:impact>Patient recruitment commenced in May 2012 initially at the Courtyard clinicand later in 2014 at the Roehampton clinic, the Burrell street clinic and at the Kingsway centre in Stevenage. Orsett Hospital, West Middlesex Hospital and Northern Devon NHS Trust are currently in the set up stage with feasibility analyses ongoing. Southend-on-sea has also expressed an interest to join the stuidy.</gtr:impact><gtr:outcomeId>5463b6aa46ed35.07414674-2</gtr:outcomeId><gtr:partnerContribution>Patient recruitment, Sample collection, Data collection</gtr:partnerContribution><gtr:piContribution>Site set up
R&amp;amp;D approvals
Site training
Site monitoring
Patient recruitment, Sample collection, Data collection
Sample preservation and transport</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Taunton and Somerset NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>eSTI2 Diagnostic Evaluations Network</gtr:description><gtr:id>FACEC983-D180-4957-AE8A-DA02C4CE5A8A</gtr:id><gtr:impact>We have successfully delivered a series of commercial diagnostic evaluations with the help of this network.</gtr:impact><gtr:outcomeId>5463ac66018615.36849344-3</gtr:outcomeId><gtr:partnerContribution>Clinics have recruited patients and provided clinical samples and data for diagnostic evaluations</gtr:partnerContribution><gtr:piContribution>We have continued to build this network through eSTI2 links e.g. GUMnet, SWAGnet and through CLRN.
We have provided clinical sites with as much training and support as needed to deliver a variety of diagnostic evaluations and am able to help build research capacity where needed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cepheid</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cepheid</gtr:description><gtr:id>75B2AD2D-F8E3-4227-A3C6-45A551DDA7FE</gtr:id><gtr:impact>Post market evaluations enabled CE marking of the device

The clinical evaluation was presented at the ISSTDR at Vienna. Manuscript in preparation.</gtr:impact><gtr:outcomeId>gQTSs8qHA7N-1</gtr:outcomeId><gtr:partnerContribution>Cepheid have loaned there Gene Expert diagnostic platform and diagnostic kits to eSTI2 for the both evaluations</gtr:partnerContribution><gtr:piContribution>1. Undertaken a post market evaluation of the Cepheid GeneXpert platform
2. Undertaken clinical evaluation of the impact of GeneXpert when deployed in sexual health clinics.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Bacterial Microarray Group at St George's (B?G@S)</gtr:department><gtr:description>Microbial community profiling in the POPI study</gtr:description><gtr:id>4D7E69C8-7009-435D-A459-DEB5D146427B</gtr:id><gtr:impact>Funding for the metagenomic work is being sought</gtr:impact><gtr:outcomeId>5463baa41fc608.02467694-1</gtr:outcomeId><gtr:partnerContribution>Grant proposal
Contribution of samples from the POPI study</gtr:partnerContribution><gtr:piContribution>Sample preparation protocol
Metagenomic sequencing protocol
Data analysis plan</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Microbial community profiling</gtr:description><gtr:id>9B7A2AC2-EF46-4A29-8217-A2664E395F2A</gtr:id><gtr:impact>The collaboration was set up in September 2014 and preliminary work on the sequencing from urine samples is currently being done. This is a multidisciplinary collaboration including genitourinary medicine, microbiology, genomics and bioinformatics.</gtr:impact><gtr:outcomeId>5463aead545dd5.07443171-1</gtr:outcomeId><gtr:partnerContribution>Protocol guidance for metagenomic library preparation
Primers for 16S rDNA PCR
Sequencing of amplicons
Metagenomic data analysis plan</gtr:partnerContribution><gtr:piContribution>Metagenomic library preparation from DNA extracted from genital samples that are well characterised with immunological and clinical data for microbial community profiling 
Optimisation of 16S rDNA PCR with primers provided by the Wellcome Trust Sanger Institute
Metagenomic data analysis plan</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>LSHTM</gtr:description><gtr:id>6F27E6DE-CCC8-4BE0-8721-D1D7F29F9FB6</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56c3382133e050.97024476-1</gtr:outcomeId><gtr:partnerContribution>Protocol development, sample provision. Discussions regarding future work in developing countries</gtr:partnerContribution><gtr:piContribution>Impact of mass drug administration with azithromycin on STI prevalence and resistance profiles
Study idea, protocol development, sample testing for M. genitalium presence and antimicrobial resistance.
Discussions regarding future work in developing countries</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Loughborough University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Microcapillary microfluidic detection assays</gtr:description><gtr:id>8D0D9194-9CC2-48F3-8DA1-57EBF61424B8</gtr:id><gtr:impact>Currently ongoing. Funding for this project has been sought by Loughborough university</gtr:impact><gtr:outcomeId>5463b98f4ece92.14587805-1</gtr:outcomeId><gtr:partnerContribution>Plan for multiplex detection of cytokines on a rapid fluoropolymer microcapillary device using initially a flurophore and later on colourimetric methods to enable mobile phone reading</gtr:partnerContribution><gtr:piContribution>Sample characterisation
Plan for comparison of cytokine detection by standard methods with a fluoropolymer microcapillary device
Clinical study protocol development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lambeth College</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lambeth College Chlamydia Testing</gtr:description><gtr:id>FA27A6C7-0F14-4BCB-BF21-89B16FFC3F37</gtr:id><gtr:impact>Publication: Sharman N1, Sri T1, Chow C2, Pond MJ2, Oakeshott P1, Planche T3, Sadiq ST4.Chlamydia testing: Reaching high-risk sexually active young people in the community. Int J STD AIDS. Epub 2015 Apr 29. 2016 Jan;27(1):78-9.</gtr:impact><gtr:outcomeId>5463b9c4846da4.22295649-1</gtr:outcomeId><gtr:partnerContribution>Lambeth College provided access to the college and students.
St George's NHS Trust provided follow up to students who were diagnosed positive for Chlamydia.
Cepheid provided a testing platform and 50 cartridges.</gtr:partnerContribution><gtr:piContribution>Planned and implemented a day of opportunistic Chlamydia testing in an inner London further education college</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Cornwall Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chlamydia Sexual Behaviour and Near-Patient Testing Network</gtr:description><gtr:id>3832DD6A-8214-4938-8111-0ABDA6B7745C</gtr:id><gtr:impact>1. Webtool: http://www.poctic.uk.net

2. User guide for webtool: Point-of-Care Tests for Chlamydia (POCTiC) Web-Tool: A tool for assessing the public health impact of introducing point-of-care testing for chlamydia

3. Abstracts and posters at UK Public health conference (Glasgow, November 2014); PHE Applied Epidemiology conference (Warwick, March 2015); BASHH (June 2015); ISSTDR (Brisbane, September 2015) 

4. Data collection complete for study: Sexual behaviour in the time period between being tested for 
Chlamydia trachomatis and receiving the test result and treatment.</gtr:impact><gtr:outcomeId>5463b1571254b6.71485650-1</gtr:outcomeId><gtr:partnerContribution>Sites provided data for sexual behaviour model.</gtr:partnerContribution><gtr:piContribution>Set up and liaised with sites to investigate the sexual behaviour in the time period between being tested for Chlamydia trachomatis and receiving the test result and treatment</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health and Care Excellence (NICE)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NICE</gtr:description><gtr:id>18AB8D88-5E78-42FB-80DE-1BDC5A1526EF</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56c337a1b84849.80416874-1</gtr:outcomeId><gtr:partnerContribution>Meeting to discuss future partnership between NICE &amp;amp; eSTI2</gtr:partnerContribution><gtr:piContribution>The NICE Medical technologies evaluation programme (MTEP) selects and evaluates new or innovative medical technologies (including devices and diagnostics). MTEP helps the NHS adopt efficient and cost effective medical devices and diagnostics more rapidly and consistently.
Meeting to discuss future partnership between NICE &amp;amp; eSTI2 in MTEP</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Microbial community profiling</gtr:description><gtr:id>9AF5905E-7C68-436B-BB2E-3F4C1AEA0305</gtr:id><gtr:impact>The collaboration was set up in September 2014 and preliminary work on the sequencing from urine samples is currently being done. This is a multidisciplinary collaboration including genitourinary medicine, microbiology, genomics and bioinformatics.</gtr:impact><gtr:outcomeId>5463aead545dd5.07443171-2</gtr:outcomeId><gtr:partnerContribution>Protocol guidance for metagenomic library preparation
Primers for 16S rDNA PCR
Sequencing of amplicons
Metagenomic data analysis plan</gtr:partnerContribution><gtr:piContribution>Metagenomic library preparation from DNA extracted from genital samples that are well characterised with immunological and clinical data for microbial community profiling 
Optimisation of 16S rDNA PCR with primers provided by the Wellcome Trust Sanger Institute
Metagenomic data analysis plan</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Atlas Genetics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Atlas CT evaluations</gtr:description><gtr:id>75A8F36A-F5FB-4CF3-88DE-F626FFAFD7F3</gtr:id><gtr:impact>CT assays for females has been CE marked using data from CT1, 2 and 3.
Clinical evaluation for CT/NG being conducted in USA using threshold cut off set in CT5.
Development of multi STI panel being developed with Innovate UK funding including CT/NG as developed in CT 1 to 5</gtr:impact><gtr:outcomeId>5463a344ba4ad3.67786558-1</gtr:outcomeId><gtr:partnerContribution>Atlas have inputted into protocol design for each evaluation and will provide consumables and funds to carry out the prescribed work.</gtr:partnerContribution><gtr:piContribution>Atlas CT 1: Assay development: Background signal determination (n=300) 
- Planned (protocol development, site specific assessments, contracts, standard operating procedures, training) and implemented study 
150 residual sample patients recruited between Sept-Nov 2014 (St George's clinic), 150 patient-consented sample patients recruited between Sept-Nov 2014 (Solent and Taunton clinics). 

Atlas CT 2: Inter-site precision study - planned and implemented. 80 synthetic samples tested in November 2015 in 4 sites: Atlas, St George's lab, Solent &amp;amp; Taunton clinics.

Atlas CT 3: Performance evaluation for CE marking (n=1500)
Planned and in final stages of implementation. 750 females recruited, and 700 males recruited to date, since Aug 2015, from 4 NHS sites (Solent, Taunton, CLCH and Chelsea &amp;amp; Westminster)

Atlas CT 5: Assay development: Background signal determination of CT/NG assay (n=300) 
- Planned (protocol development, site specific assessments, contracts, standard operating procedures, training) and implemented study 
150 residual sample, and 150 patient consented patients recruited in 2016 (St George's clinic),</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>SELECTBIO - India</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FED772B0-90AB-416D-8512-17FB28331A6F</gtr:id><gtr:impact>Balachandran W, &amp;quot;Sequentially Linked Integrated Cassette for Molecular Diagnostics-SLIC MDx&amp;quot;, Microfluidics, Liquid Handling &amp;amp; Lab-on-a-Chip Conference, organised by SELECTBIO-India, Mumbai, 18-19 January 2017 - Keynote Presentation</gtr:impact><gtr:outcomeId>58bfc0d5d23de1.61382161</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU Observer</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1334B875-244F-42BB-B99F-8F6F285E974F</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>iGCvt2ZHsxt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab on a Chip World Congress</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D99859F1-0D68-45E2-BF44-AD4105BE710B</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54665d8ef1c095.95091766</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>St Georges Research Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>40AFB545-C8EE-413F-AABE-AA703D62C8F4</gtr:id><gtr:impact>4 Posters</gtr:impact><gtr:outcomeId>58b94ec8b944c4.29636265</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Network Enterprise Europe</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>923CA2C7-902F-46F3-953B-9CF31DFA815A</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>LoiVKvAxSod</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carbohagen</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F0AF37E4-53C6-4ACE-A633-BC6A6F2EC92A</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>eLGMABaCnA1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Med Tech</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>061BFCF1-9619-489B-8026-59EC2C08D297</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>Nueg8rDJdxa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IUSTI world congress 2016, Marrakesh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F0FE2CA5-37D7-4D74-9DD8-744CAC288AD3</gtr:id><gtr:impact>2 Oral presentations</gtr:impact><gtr:outcomeId>58c66b4f178a99.31281781</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BSIG</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>791F9E8F-9B84-4CD9-BC53-1D8480E58504</gtr:id><gtr:impact>Works with BASHH to provide educational and research support in the field of sexually transmitted infections</gtr:impact><gtr:outcomeId>58b9499cc0c547.20616979</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.bashh.org/bashh-groups/special-interest-groups/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biosensing Knowledge Transfer Network</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2632C4B5-5A21-43BC-B93C-4AC914D919BA</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54665d5f196829.11594705</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK-India Workshop on Tackling the Emergence of Antimicrobial Resistance: Increasing Awareness and Facilitating Research Networks. 7-10 November 2016 Chandigarh, India</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A452E030-6B08-405F-B163-18F3D89F57F0</gtr:id><gtr:impact>This was a highly successful workshop addressing the challenges of antimicrobial resistance internationally</gtr:impact><gtr:outcomeId>58c7c720b08f06.05880472</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Life Long Health Domain Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4AA3E4BA-3F48-4644-97F2-A5906BE4A563</gtr:id><gtr:impact>Presentation on Online STI / HIV management</gtr:impact><gtr:outcomeId>58b94f40b8ce93.66641868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biosensors 2014 (2)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E87BEF94-5E12-4E5F-8B3E-BCDBBB30A029</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>546623d55ff438.14036386</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Micro and Nano Flows</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32FDEF6D-8A1A-4F4D-9092-A3C843B847F6</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>546623006da731.64827525</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sample Prep East</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>51ECA701-0FA9-4E44-85CD-6065F92251E3</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5466405e2f1a13.77485166</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brunel Diagnostics for the Developing World symposium</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF6D3B9F-E236-4EFC-891A-A852AF001080</gtr:id><gtr:impact>Presentations:
&amp;quot;Antimicrobial resistance and point of care tests for sexually transmitted infections&amp;quot;
&amp;quot;Development of a tool for assessment of the impact of introduction of point-of-care tests for STIs&amp;quot;</gtr:impact><gtr:outcomeId>56c47632583eb9.20988262</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BASHH 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0778F6FA-08AD-47E7-9522-94FD08ABF56F</gtr:id><gtr:impact>Poster and oral presentations:
&amp;quot;&amp;quot;Can I get treated online?&amp;quot; Using the eClinical Care Pathway Framework to develop an evidence based online clinical care pathway for management of people with genital chlamydia&amp;quot;
&amp;quot;Sexual behaviour in the time period between being tested for chlamydia and receiving test result and treatment&amp;quot;
&amp;quot;A facility to enable high-quality, time-efficient evaluations of diagnostics for STIs&amp;quot;
&amp;quot;Testing and treating STIs in hard to reach populations&amp;quot;</gtr:impact><gtr:outcomeId>56c47582d8e0c9.81399950</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Lab Automation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1A5D0AD3-CDE3-4E3A-B39D-33013C7A4DA9</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54665d23d8e8c9.72537075</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Health Protection Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EBFF6C1C-6E3E-4B66-84EE-611C35592DD9</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>dv1i6V2GVLN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IUSTI World Congress 2015, Sitges</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C7AD8EA3-8A3F-4AE4-B7FF-B274E917A1BF</gtr:id><gtr:impact>Oral presentation</gtr:impact><gtr:outcomeId>58b94c6d98df50.88501036</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ESCR 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>276B211A-B873-44FD-98B3-62973094CA94</gtr:id><gtr:impact>2 Posters

Atlas Genetics had a stand and Precise Study brochures were distributed</gtr:impact><gtr:outcomeId>58b94af4c939f1.05613940</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BASHH Diagnostics Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2EC8002C-EF0C-42ED-A12B-4B5876F21B87</gtr:id><gtr:impact>Tariq Sadiq gave an oral presentation, and a review of the meeting was published: http://journals.sagepub.com/doi/abs/10.1177/0956462416628782?ai=1gvoi&amp;amp;mi=3ricys?=R</gtr:impact><gtr:outcomeId>58c665adcdb978.84068876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Achieving a World Without Medication Error</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>381C217A-EC80-423A-87FD-148601002124</gtr:id><gtr:impact>Gibbs J, Sutcliffe L, Aicken C, Tickle L, Wu S, Shimmin H, Ashcroft RE, Sadiq ST, Sonnenberg P, Estcourt C. A novel ePrescribing System linking an online eSexual Health Clinic &amp;amp; Community Pharmacies. 
Achieving a World Without Medication Error: e-Prescribing and Medication Management Symposium, School of Pharmacy, UCL. 25th November 2016.</gtr:impact><gtr:outcomeId>56c33623a271d4.99665562</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chlamydia Serology Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE8D3800-E124-438D-A23C-2ED80E187C00</gtr:id><gtr:impact>To understand the role of Chlamydia serology assays</gtr:impact><gtr:outcomeId>58b94b713c4217.19007057</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SWAGNET</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BC33906E-AF5C-4075-B48B-9F2CC4AD0D85</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>a4Y9QEQPjWb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rutherford Appleton Laboratory</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>01CF7F24-A44C-4332-83F4-8709EF32923D</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5466243f532aa7.31405548</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PHE National Infection Service Emerging Infectious Diseases</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E0887307-B77D-4464-8392-A288E2E1A4CB</gtr:id><gtr:impact>Oral presentation of work conducted by SGUL's Applied Diagnostic Research and Evaluation Unit (ADREU), including Precise and eSTI2</gtr:impact><gtr:outcomeId>56c4822309bff6.49486194</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nanopore Community Meeting 2016. The Metropolitan Pavilion, New York</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>474097AD-986A-4EE5-B2FC-8139CE045089</gtr:id><gtr:impact>An opportunity to present our work at the nanopore meeting</gtr:impact><gtr:outcomeId>58c7cb4134b957.86206810</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://nanoporetech.com/events/ncm16</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Society for STD Research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>59D08F48-C7ED-411E-8A70-27EEAEFA9282</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>oCZnUX6cGVP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BioSensing Knowledge Tranfer Network</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E83CC2BF-8D60-4533-A3EC-84D8DE66730D</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>LyP4gWDtSiY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IUSTI world congress</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6E7AE434-C943-4FBC-8DF8-89180CD130B5</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>iiuGHjriVmm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GRASP collaborators meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>503533A8-4B54-4901-A722-A4C0BE997FAC</gtr:id><gtr:impact>Presentation on diagnostics for NG and AMR</gtr:impact><gtr:outcomeId>58b94db95f7289.57459735</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Lab Automation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9914A527-CAA1-4F9D-9A02-6959F8D856FD</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>d2cHoPhJX22</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biosensors 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9094ABDB-047B-4083-8C0C-B4DCBDFB6F16</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5466233e2a2f12.48149460</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sexual Planning for London 2012 Olympic Games</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E3B3CFAF-4DF2-4BA4-879D-C1A53DE11D78</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>aEKx6gkFf6k</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of the ECDC STI and HIV Networks, Bratislava</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>11A11686-6382-441C-B7B3-E3EE5830CFBE</gtr:id><gtr:impact>Meeting on Rapid Point of Care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance. Dissemination of Research and creation of scientific collaboration. Future collaborations planned</gtr:impact><gtr:outcomeId>56f115cae7fb77.22626773</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISSTDR 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>79E785B0-F993-4A50-9878-28C499DCDF3E</gtr:id><gtr:impact>eSTI2 undertook 7 poster presentations and 2 oral presentation

The e-clinical pathway presented to the conference was accepted as cutting edge in feedback from peers.</gtr:impact><gtr:outcomeId>56681ca3d75e57.29549669</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BASHH Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CF04CC2B-2A46-4BA2-B803-D3473DF3CA86</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>anXW6WK2gnM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute for Infection and immunity Away Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F12EA3AF-C956-4FBA-9D47-325160097465</gtr:id><gtr:impact>Presentation on ADREU diagnostics evaluation service</gtr:impact><gtr:outcomeId>58b94cedda5156.80751291</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AMR Information and Networking Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>96E4932C-E74E-4A57-920C-5E35B02DEFBE</gtr:id><gtr:impact>AMR Information and Networking Event &amp;quot;Antimicrobial resistance: behaviour within and beyond the healthcare setting&amp;quot;, Amba Hotel Marble Arch, London, Tuesday 14 June 2016. Presentation &amp;quot;A clinician's perspective&amp;quot; presented by Dr Tariq Sadiq</gtr:impact><gtr:outcomeId>58b94d50c6eb78.41066994</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Jenner Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>28798782-62BA-43BF-91C8-982E49D89E23</gtr:id><gtr:impact>Presentation Enabling rapid personalised medicine and realtime AMR surveillance for Global Advanced health systems</gtr:impact><gtr:outcomeId>58b94e78995eb3.40338411</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Federation of Infection Societies Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F78A88F3-CCDB-42C2-9781-BC2270FDF6C7</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54635a2005bbc6.62016387</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ECCMID Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>049EF218-ABA5-4CF9-A5D1-EE4DA52AAF34</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5463812a303af7.56760524</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Festival for Digital Health</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>806D7FF2-DAF4-4311-A84D-4E9EEB3D5ACA</gtr:id><gtr:impact>Presentation by Aicken C, Sonnenberg P, Estcourt C, Johnson A, Mercer C. Who uses the internet for sexual healthcare? Evidence from a nationally-representative survey of the British population. 
UCL Festival for Digital Health, London, UK, 23-25th June 2014.</gtr:impact><gtr:outcomeId>56c335d3cf26b4.67285314</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ChiNano</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7548372A-EC47-494A-9A4F-31155D149CB5</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>ZhDHz9hnzGv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research, Innovate, Grow conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87D265F6-078F-44BF-9289-AF316D65100E</gtr:id><gtr:impact>Presentation of the eSTI2 diagnostic evaluation capabilities

Significant interest in the service that eSTI2 are proposing to provide</gtr:impact><gtr:outcomeId>56962d6a44e8b1.92523563</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BASHH 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>560F15AC-E50C-49C1-8600-2EACE8E26411</gtr:id><gtr:impact>4 abstracts accepted
3 Posters
1 Oral presentation

Atlas Genetics had a stand.</gtr:impact><gtr:outcomeId>58b94a99cdb8e4.12426361</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.bashh.org/events/annual-conference/annual-conference-2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>98C2EFF5-6E54-48DB-B01F-1A495A0BA05B</gtr:id><gtr:impact>Multiple media publications and enquiries about the research

Multiple newspaper and magazine articles all over the world describing the eSTI2 programme</gtr:impact><gtr:outcomeId>Xt9MSUj8v39</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GUMNet Steering Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>06A4706C-8FBF-47BA-A50D-FC59FD0BA81B</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>NXX7LAh7f1m</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UKCRC Syposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DE475DF2-CF2C-4903-A5D4-ACEB405F0701</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>hK3EYkfThhs</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sensors in Medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3872EEA7-2134-4A51-86B6-A1DF499391FE</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>5466240eb54334.49166509</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>783A892B-F297-4148-B5BE-830182595422</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>UPmine37xGV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NanoKTN</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>31299970-F51F-4BDB-92A1-6AB16B79117D</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>nVPrvdqU2v3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SELECTBIO - Singapore</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>349029C7-C1E5-497E-8021-802BD82FE460</gtr:id><gtr:impact>Balachandran W, &amp;quot;Sequentially Linked Integrated Cassette for Molecular Diagnostics - SLIC DX&amp;quot;, Lab-on-a-Chip Asia Conference, organised by SELECTBIO-Singapore, 5-6 December 2016 - Invited presentation</gtr:impact><gtr:outcomeId>58bfc064462f38.81815801</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Point-of-care test symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>70D6177A-8249-469F-A8A2-87FF6937597C</gtr:id><gtr:impact>Point-of-care testing symposium organised by Public Health England (result of the Innovate UK POCTiC web-tool SBRI grant). Tariq Sadiq gave a talk entitled &amp;quot;Antimicrobial resistance and point of care tests for sexually transmitted infections&amp;quot;</gtr:impact><gtr:outcomeId>58c66430abdee2.44457430</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carbonhagen</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA392005-EA45-4E7E-91B3-7967D7C7E7FF</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54665ca458d369.91169439</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab on Chip Congress</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>143D0758-D8B5-4CD0-9771-4865DB0A37A0</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>ELDs7j8BnYo</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab on a Chip</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>90C84B39-1CD2-4DF7-8830-E22F1D36E291</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>VxNskJhkAg1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diagnostics in the Developing World 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2655B2E0-8DAA-4686-BBBD-3E54D19A80AB</gtr:id><gtr:impact>Diagnostics in the developing world conference co-sponsored by eSTI2. 
Balachandran W, &amp;quot;Low Cost Molecular Diagnostics for the Developing World&amp;quot;, Diagnostics and the Developing World Conference, London, 23-25 January 2017 - presentation

Enabling Rapid Personalised Medicine and Real-Time Antibiotic Resistance Surveillance for Global and Advanced Health Systems, Dr.Tariq Sadiq,St. George's University of London</gtr:impact><gtr:outcomeId>58b95059899b00.84316372</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISSTDR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D8BF4A22-8069-4250-B31A-0F18FA84CC7F</gtr:id><gtr:impact>STI &amp;amp; AIDS World Congress 2013
July 14 to 17, 201
Hofburg Congress Center, Vienna.
What are young people's perceptions of using electronic self-tests for STIs linked to mobile technology for diagnosis and care (eSTI2)? 
Fuller, SS; Aicken C; Sutcliffe LJ; Estcourt CS; Gkatzidou V; Hone K; Sonnenberg, P; Oakeshott, P; Sadiq, ST; Shahmanesh, M.

-</gtr:impact><gtr:outcomeId>Zt5RKDq2E3m</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://sti.bmj.com/content/89/Suppl_1/A69.3.abstract</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Lab Automation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C8800624-C7C8-48C8-9843-DC5E5C0083AE</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>efFSFbuBnNt</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IUSTI Malta 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BEC621FA-5518-41E1-8CAB-BA9BE70F1AA4</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54635a77293552.55876258</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ChiNano</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>65BA62ED-0C1C-4698-A645-30F886306675</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>54665cee854598.00883189</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BiosensingKTN</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>15D1170A-CB9E-4079-B1E4-7FF6FBC34336</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>PP3zRBvz1eE</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Innovate 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>337A8550-0405-4889-AAEA-E6C97890B7AF</gtr:id><gtr:impact>Brunel presented the PoC CT platform (Felix)

Precise Study brochures handed out

Significant interest in device especially speed of assay</gtr:impact><gtr:outcomeId>56963010f0b598.28066836</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MicroTas</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>98F02940-5DD6-41A1-8E0B-FBC25D98B854</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>XnDmuegu2w3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Med-Tech</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>28DD448B-5EBD-4280-AB45-454FBE056A5E</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>QrqfidyNx8U</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SBRI</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>SBRI Healthcare</gtr:fundingOrg><gtr:id>F7F794EE-72A7-4BEE-9937-5CDF27524383</gtr:id><gtr:outcomeId>54647b59062227.34138613</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EUMinaFab</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>78267E83-3FEA-4005-97B0-CDC300F8E17C</gtr:id><gtr:outcomeId>54663ff8009ed3.28693210</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR i4i Invention for Innovation (i4i) Programme</gtr:department><gtr:description>Invention for Innovation Programme</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>II-LB-0214-20005</gtr:fundingRef><gtr:id>34572461-DFE3-47A4-A5DC-2F0DD0B3F0A2</gtr:id><gtr:outcomeId>566fffe5a57a60.55414911</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant</gtr:description><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>FFD15B73-828B-4797-8AED-9780B8120DD6</gtr:id><gtr:outcomeId>FbTSXAWmsAB</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant</gtr:description><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>F09C9608-8A6D-4607-8854-EF1221813F7B</gtr:id><gtr:outcomeId>JexHb7eGhcW</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1481876</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>i4i</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>II-LB-0214-20005</gtr:fundingRef><gtr:id>EDFEFBED-B21E-4ED8-939B-5FB45189F41B</gtr:id><gtr:outcomeId>54621cb39c4e21.09553688</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>436115</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Detection and Identification of Infectious Agents SBRI</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:fundingRef>15933-107158</gtr:fundingRef><gtr:id>D4F47988-8BCF-4A81-8E07-6E77AACC68AF</gtr:id><gtr:outcomeId>DddHDN57EqP</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>923223</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rapid diagnostics for human and bovine tuberculosis.</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>67D88481-9387-48FD-AEE0-1C1398E5085F</gtr:id><gtr:outcomeId>Fam8wtY1ETP</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>249734</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RfPB</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>PB-PG-1014-35007</gtr:fundingRef><gtr:id>FD907E72-4F3E-4B05-8590-37B8DDD6FAC1</gtr:id><gtr:outcomeId>56c1cc66697252.64081296</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Researcher Visibility Award</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Brunel University London</gtr:fundingOrg><gtr:id>07361BAF-089C-4AE3-BBB3-834C04C18CF1</gtr:id><gtr:outcomeId>5643273ced8500.64008172</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3997530</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Framework 7</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>304948</gtr:fundingRef><gtr:id>29162AFB-A9B9-4CD3-B44A-FC1028149FAC</gtr:id><gtr:outcomeId>DwXJ7b6n8p6</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Society For General Microbiology -Expert Panel on STIs</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BE95AB6F-AD34-4A83-9078-41764134FA9C</gtr:id><gtr:outcomeId>hu47HR8NwNH</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bacterial Special Interest Group. Development of a Handbook of Microscopy for Diagnosing Sexually Transmitted Infections</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>27A2F4A3-0CD8-4E4B-8401-D0FC17C90307</gtr:id><gtr:outcomeId>58c7bda4c89749.92701278</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair of the National Guidelines for the management of gonococcal infection, British Association for Sexual Health and HIV</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>20F9ACD9-B7BE-42D9-AD97-EE93BE37F63C</gtr:id><gtr:impact>As lead for the National Guidelines for the management of gonococcal infection committee for the British Association for Sexual Health and HIV, I have been responsible for discussing and disseminating opinions of key opinion leaders in the field for practitioners. Publication of the guidelines will take place later this year.</gtr:impact><gtr:outcomeId>58c7ba80d0ebe6.85052579</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ECDC Report : Novel approaches to testing for sexually transmitted infections, including HIV and hepatitis B and C in Europe</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>3E9AA70B-805D-42F3-9AA1-23ECDDD20CBD</gtr:id><gtr:outcomeId>YZjsDPAh3xV</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>eSTI2 has completed a 50 patient residual sample study using the Cepheid GeneXpert platform that rapidly diagnoses gonorrhoea and chlamydia by NAAT</gtr:description><gtr:id>7F99EDC7-E7AC-4EB0-BAB3-C630986B6D85</gtr:id><gtr:impact>STI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>56681939482c24.46713252</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Cepheid Gene Expert 1</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Development of a rapid point of care Chlamydia &amp;amp; Gonorrhoea diagnostic tool. TwistDx Ltd were supplied with 100 residual urine samples for the aim of developing their Recombinase Polymerase Amplification (RPA) based assay.</gtr:description><gtr:id>E80C3B0E-716D-4EB4-AEFC-4EE3C4E6528F</gtr:id><gtr:impact>eSTI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>56680e0dcea825.68567033</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Twist PCE1</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>eSTI2 has collected over 800 patient consented samples to enable assay development / evaluation of the TwsitDX RPA assay. The samples have been provided to TwistDx via a service agreement</gtr:description><gtr:id>4CE7EC83-89AF-4350-ABEF-1E1132815793</gtr:id><gtr:impact>Part of the eSTI2 evaluation development infrastructure rollout.</gtr:impact><gtr:outcomeId>566815f63514d5.57501141</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TwistDx PCE3</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Subsequent to evaluation Twist PCE1 an additional patient consented sample collection was undertaken to enable TwistDx to choose the appropriate swab for female sample collection for their Chlamydia &amp;amp; Gonorrhoea diagnostic tool.</gtr:description><gtr:id>6B272AB6-7179-4282-8DBF-82F9DD6FFF92</gtr:id><gtr:impact>STI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>56680f2b4974c5.41766758</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TwistDx PCE2</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Healthcare diagnostics are developing a rapid test platform as a diagnostic tool. eSTI2 have supplied 3 sets of residual urine samples (total 966 samples) for CT assay development</gtr:description><gtr:id>62C23A22-8525-428B-921E-1CCAFA382FC2</gtr:id><gtr:impact>STI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>566818111c99c0.66413993</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Healthcare diagnostics</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Diagnostic performance evaluation of 750 female patient-consented samples, and 750 male urine samples</gtr:description><gtr:id>99E153AF-F629-45AE-84CB-5CA2E4F5D7CA</gtr:id><gtr:impact>The full spectrum of evaluation has been demonstrated from early assay development via clinical samples through to diagnostic performance evaluation for CE marking.

This has lead to the setup of a diagnostic evaluation service run from St Georges University London called the Applied Diagnostic Research and Evaluation Unit (ADREU)</gtr:impact><gtr:outcomeId>566febb95ba276.42374535</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Atlas CT3</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>eSTI2 completed for the Cepheid GeneXpert an evaluation of health provision, outcomes and patient perspectives to assess the impact of introducing Cepheid GeneXpert into a sexual health clinic</gtr:description><gtr:id>D5EADDFD-AB19-4BF7-AF03-F040827850E1</gtr:id><gtr:impact>STI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>566819d4b32461.73193734</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Cepheid Gene Expert 2</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Provision of 150 male residual samples for Atlas CT assay development</gtr:description><gtr:id>E0674F77-3077-4A86-B46D-54D7FBF4AFF8</gtr:id><gtr:impact>STI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>56681a8915c1d2.76090729</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Atlas CT1A</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Provision of 150 patient consented female samples for assay development.</gtr:description><gtr:id>B7424100-D0E8-4027-8795-8B8A910A2BB8</gtr:id><gtr:impact>STI2 has developed a process and infrastructure where third parties can access independent clinical evaluations. This infrastructure includes provision of samples to clinical trials. This evaluation / provision of samples is to work with clients to develop the capability.</gtr:impact><gtr:outcomeId>56681ae8427983.38118306</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Atlas CT1B</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>This is a web-application tool developed in collaboration between eSTI2 partners (QMUL, UCL, Brunel, Warwick and SGUL) that allows patients who receive their Chlamydia diagnosis while outside clinic via text to access care and treatment without having to re-attend clinic. It is electronically linked to pharmacies and has built in safeguards to prevent patients inappropriately accessing the pathway (e.g. those with potential complications of infection) and that enable patients to link in with healthcare workers at any part of the pathway. Pilot trials undertaken in collaboration with the National Chlamydia Screening Programme, Barts and The London Healthcare Trust and St George's Healthcare NHS Trust, have now been completed.</gtr:description><gtr:id>D729DD8C-B495-4EFE-BC87-5F1022DAB463</gtr:id><gtr:impact>Nil yet</gtr:impact><gtr:outcomeId>5463b75e9c8681.56565169</gtr:outcomeId><gtr:title>A web-tool for managing Chlamydia infection diagnosed in the community</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>This is an behaviour questionnaire that is intuitively administered by an algorithm to collect data on sexual behaviour and socioeconomic status anonymously.</gtr:description><gtr:id>AAE23740-6570-490B-8AF1-D7F7837ACEA7</gtr:id><gtr:impact>Data collection underway</gtr:impact><gtr:outcomeId>5463bcc11dd097.98167238</gtr:outcomeId><gtr:title>PolySTI computer assisted self-interview for behaviour</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>This tool, which is part- funded by the Grant and also by Innovate UK, allows for industry and Healthcare commissioners to understand the cost and epidemiologic impact of introducing point of care testing into their local setting in the UK. Variables include local prevalence of infection as well as putative accuracies of the tests being introduced.</gtr:description><gtr:id>5C00BC52-6505-4AAB-BE1C-EDF3AE9EFD51</gtr:id><gtr:impact>nil yet</gtr:impact><gtr:outcomeId>5463b8580ae320.66562890</gtr:outcomeId><gtr:title>POCTIC</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Software enabling mobile phone cameras to interact with rapid diagnostic tests</gtr:description><gtr:id>8E3D52F2-8301-441A-938E-BAC8BAAB71FE</gtr:id><gtr:impact>Nil yet</gtr:impact><gtr:outcomeId>5463b8972690c7.45203552</gtr:outcomeId><gtr:title>POC Mobile Phone Reader</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>13B7DBDD-2874-4D5F-AAA3-D20CD9A9CACB</gtr:id><gtr:title>The eSexual Health Clinic system for management, prevention, and control of sexually transmitted infections: exploratory studies in people testing for Chlamydia trachomatis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb172f98c3b3cae2335f97846123cefe"><gtr:id>cb172f98c3b3cae2335f97846123cefe</gtr:id><gtr:otherNames>Estcourt CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a9675dbe4ffb7.18199077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42E016EA-07E8-4BC8-B2E4-B950CE1EEE44</gtr:id><gtr:title>P12.01 Getting your chlamydia care online: qualitative study among users of the chlamydia online clinical care pathway (chlamydia-occp), in a proof of concept study</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7d6095f02fd97306e51f12e9d86e626"><gtr:id>d7d6095f02fd97306e51f12e9d86e626</gtr:id><gtr:otherNames>Aicken C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>564321fe958c92.24266829</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC1BF34B-C56E-46F8-8744-B487319219B6</gtr:id><gtr:title>P5.058 A Review of the Landscape of Mobile-Phone Applications For Information, Education, Diagnosis, Care and Self-Management of Sexually Transmitted Infections (STIs)</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a08dfe045fab91dde38932cfb1d271b"><gtr:id>2a08dfe045fab91dde38932cfb1d271b</gtr:id><gtr:otherNames>Gkatzidou V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5463732c652f88.76721044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18B39EB7-7CC3-42E4-8D50-118453764046</gtr:id><gtr:title>Process of Designing Robust, Dependable, Safe and Secure Software for Medical Devices: Point of Care Testing Device as a Case Study</gtr:title><gtr:parentPublicationTitle>Journal of Software Engineering and Applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e45b69542ad01c50bc793e6db0ce4c9"><gtr:id>4e45b69542ad01c50bc793e6db0ce4c9</gtr:id><gtr:otherNames>Tulasidas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_13576_013_69A001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EE5287D-9290-4846-AC7F-72625CEAD4AA</gtr:id><gtr:title>P193 Development of a handheld point of care molecular diagnostic device for sexually transmitted infections</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a569bf8283087973fdc15d784e87c21"><gtr:id>5a569bf8283087973fdc15d784e87c21</gtr:id><gtr:otherNames>Mackay R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>564315e0a7ad79.92423440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C034FA14-832B-4060-AB0D-2036A3E1A487</gtr:id><gtr:title>005.2 Diagnostic and clinical implications of genotypic fluoroquinolone susceptibility detection for</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed182e32814b009088adef9fced1314"><gtr:id>aed182e32814b009088adef9fced1314</gtr:id><gtr:otherNames>Pond M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5643185d51a903.07212830</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C5F0EE6-049E-49D3-B47A-DEDAD526D7E0</gtr:id><gtr:title>P08.28 Patients continue to engage in risky sexual behaviour in the time period between being tested for chlamydia and receiving test result and treatment</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56431b36ea6b23.10517952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>205A6E61-4F01-4866-953C-226AA1029A99</gtr:id><gtr:title>How likely is environmental or patient cross-contamination of Chlamydia trachomatis DNA to lead to false positive results in patients attending our clinic?</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebdd9c43c7abd9c316721ce6d3e0b9f9"><gtr:id>ebdd9c43c7abd9c316721ce6d3e0b9f9</gtr:id><gtr:otherNames>Chan SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_13576_26_23038711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>025AC5EA-27E2-4D88-BBFE-7507A57313DE</gtr:id><gtr:title>A Simple, Low-Cost Platform for Real-Time Isothermal Nucleic Acid Amplification.</gtr:title><gtr:parentPublicationTitle>Sensors (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a21e21d4da9078fb60b8b01070e1c486"><gtr:id>a21e21d4da9078fb60b8b01070e1c486</gtr:id><gtr:otherNames>Craw P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1424-8220</gtr:issn><gtr:outcomeId>56324a25f33627.44676665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1EA8F89-3F01-4BEB-A945-CDD524F0F115</gtr:id><gtr:title>O1 Rapid automated white cell urinalysis is more accurate than urethral smear for predicting chlamydia infection in men</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed182e32814b009088adef9fced1314"><gtr:id>aed182e32814b009088adef9fced1314</gtr:id><gtr:otherNames>Pond M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>58b96ef6cfb792.08895489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0252F5B-5817-40D5-934D-80001EA0952F</gtr:id><gtr:title>Chlamydia related bacteria ( Chlamydiales ) in early pregnancy: community-based cohort study</gtr:title><gtr:parentPublicationTitle>Clinical Microbiology and Infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50ffd93ca63e09e06ec43e39b3e598ce"><gtr:id>50ffd93ca63e09e06ec43e39b3e598ce</gtr:id><gtr:otherNames>Reid F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58ac53cc48f0e2.36472548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B026AC73-21C7-42D5-B1E3-6BFC5634D020</gtr:id><gtr:title>Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/677dbd658e15e70352207a50856620c2"><gtr:id>677dbd658e15e70352207a50856620c2</gtr:id><gtr:otherNames>Pond MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>56c1cae934e694.19835029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F60A0B4E-D864-49C8-807F-A58006EC2BF9</gtr:id><gtr:title>P65 Sexual behaviour in the time period between being tested for chlamydia and receiving test result and treatment</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>58b96ef67b2fa9.95380071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C570F2-04A6-4BB7-8F0A-10EC43B83A8A</gtr:id><gtr:title>Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases.</gtr:title><gtr:parentPublicationTitle>Journal of oral microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7add4ea660ca32558080efbe8a8e1cbb"><gtr:id>7add4ea660ca32558080efbe8a8e1cbb</gtr:id><gtr:otherNames>Nibali L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2000-2297</gtr:issn><gtr:outcomeId>546353a092bef5.69658776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F717045B-6A22-4A7B-91D5-4A85F96C63BB</gtr:id><gtr:title>P5.098 Clinical Prediction of Fluoroquinolone Susceptibility, Directly from Residual Routine NAAT Gonococcal-Positive Samples Using a
 
 SNP Detection Assay</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8094e2360d1e6be7f813d670d0fe1d5"><gtr:id>f8094e2360d1e6be7f813d670d0fe1d5</gtr:id><gtr:otherNames>Miari V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546376fa5fc750.97653271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EE84C62-6BB2-433A-ABA5-4F1BA391E710</gtr:id><gtr:title>Point-of-care testing versus standard practice for chlamydia: a new approach to assessing the public health effect of rapid testing and treatment at local level</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6c9113d4dc262d1600d50c5f83e7c03"><gtr:id>a6c9113d4dc262d1600d50c5f83e7c03</gtr:id><gtr:otherNames>Lowndes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56c1ba9fd2ae35.52177535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7477E7E8-4FDC-4976-8CC5-A5D0178156AD</gtr:id><gtr:title>P2.113 Urinary Calprotectin: A Biomarker of Urethral Inflammation</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5d4322ad2c14e3dd60b89dd6894840c"><gtr:id>c5d4322ad2c14e3dd60b89dd6894840c</gtr:id><gtr:otherNames>Nori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>54637b2e837e93.65485077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AE61FE9-DA40-48D6-B734-22B6059AA3AE</gtr:id><gtr:title>DEVELOPMENT OF AN AUTOMATED ONLINE CLINICAL CONSULTATION WITH ELECTRONIC ANTIBIOTIC PRESCRIBING FOR THE REMOTE MANAGEMENT OF GENITAL CHLAMYDIA TRACHOMATIS INFECTION WITHIN THE ESTI2 CONSORTIUM</gtr:title><gtr:parentPublicationTitle>SEXUALLY TRANSMITTED DISEASES</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd9a964cc48658bc2626bf1d7786d459"><gtr:id>cd9a964cc48658bc2626bf1d7786d459</gtr:id><gtr:otherNames>Gibbs Jo</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>56c1d68f0f93a9.18452083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CF76731-CB2E-454B-B205-8DDFAEE4ADB3</gtr:id><gtr:title>O10.2 A performance evaluation of the atlas genetics ltd io&amp;reg; system: a novel and rapid point-of-care in vitro diagnostic test for</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b11767e3117d4b6c4a2e0bbe8f32611c"><gtr:id>b11767e3117d4b6c4a2e0bbe8f32611c</gtr:id><gtr:otherNames>Cousins E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a96c807f40828.66771913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A937A46-394E-46B5-9E10-A6040C56C8DA</gtr:id><gtr:title>Can remote STI/HIV testing andClinical Care be compatible with robust public health surveillance?</gtr:title><gtr:parentPublicationTitle>DH'15: proceedings of the 5th International Conference on Digital Health 2015 : May 18-20, 2015, Florence, Italy. International Conference on Digital Health (5th : 2015 : Florence, Italy)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56965f5fef9479.27960608</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9A437DA-3570-4542-AC9E-CBF144B81465</gtr:id><gtr:title>High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/677dbd658e15e70352207a50856620c2"><gtr:id>677dbd658e15e70352207a50856620c2</gtr:id><gtr:otherNames>Pond MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>hzC3kkz4tez</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3BA8279-615F-4092-8E89-BEAAB79D826D</gtr:id><gtr:title>Point-of-care antibiotic susceptibility testing for gonorrhoea: improving therapeutic options and sparing the use of cephalosporins.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7b577ba1934730b79df75b949675e1b"><gtr:id>f7b577ba1934730b79df75b949675e1b</gtr:id><gtr:otherNames>Sadiq ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_13576_26_20940156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4679C227-7F66-4BEA-979C-4BA806E75D9F</gtr:id><gtr:title>OP34 Online care for sexually transmitted infections: using qualitative research in intervention development and evaluation</gtr:title><gtr:parentPublicationTitle>Journal of Epidemiology and Community Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7d6095f02fd97306e51f12e9d86e626"><gtr:id>d7d6095f02fd97306e51f12e9d86e626</gtr:id><gtr:otherNames>Aicken C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5838348dcc6211.36748540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A92AA344-0BBC-4E2A-874C-02F662DAA2C6</gtr:id><gtr:title>O010 Use and perceptions of the
 
 : findings from qualitative interviews among people treated for chlamydia</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7d6095f02fd97306e51f12e9d86e626"><gtr:id>d7d6095f02fd97306e51f12e9d86e626</gtr:id><gtr:otherNames>Aicken C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5838348e00a706.34046884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C8291CD-C13F-427F-BC30-B81B6858E455</gtr:id><gtr:title>Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21b671a1debaffd29c5758b1da444c81"><gtr:id>21b671a1debaffd29c5758b1da444c81</gtr:id><gtr:otherNames>Pathak N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>54637cec541a63.33194269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D86071A1-43F6-4B20-9171-B8DE1E7DD7F2</gtr:id><gtr:title>P3.94 Does mass drug administration with azithromycin for trachoma control have an impact on the prevalence and macrolide resistance of genital
 
 infection?</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96b95dda0c6845feada7830a37380866"><gtr:id>96b95dda0c6845feada7830a37380866</gtr:id><gtr:otherNames>Harrison M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a96c80792ee66.64177952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>245580B6-A3B0-49B3-9FAE-110A698DBC1E</gtr:id><gtr:title>O22.4 What Are Young People's Perceptions of Using Electronic Self-Tests For STIs Linked to Mobile Technology For Diagnosis and Care (eSTI2)?</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32b6cf065d0ccc6c2f06b0c4405d61c1"><gtr:id>32b6cf065d0ccc6c2f06b0c4405d61c1</gtr:id><gtr:otherNames>Fuller S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546374c53e05b0.81643142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA8F201F-7BD1-45EF-B985-E7440CCF2AAA</gtr:id><gtr:title>Young people's perceptions of smartphone-enabled self-testing and online care for sexually transmitted infections: qualitative interview study.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3aadb7cac30608485e670e5d0b39f1c"><gtr:id>d3aadb7cac30608485e670e5d0b39f1c</gtr:id><gtr:otherNames>Aicken CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>5838348d9caa62.11941725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66CE107E-9AB6-40D1-8B4E-F303E7D75DA6</gtr:id><gtr:title>P169 Comparison of the FTD? Urethritis Plus (7-Plex) detection kit with routine sexual health clinic nucleic acid amplification testing for detection of
 
 and
 
 in urine, vaginal, pharyngeal and rectal samples: Abstract P169 Table 1</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96b95dda0c6845feada7830a37380866"><gtr:id>96b95dda0c6845feada7830a37380866</gtr:id><gtr:otherNames>Harrison M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b96ef5e6b9d8.42617413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82A28F1C-4FA4-40B9-9716-5655FD368DCB</gtr:id><gtr:title>P09.13 Impact and cost-effectiveness of point-of-care testing for chlamydia: accounting for geographic variation in infection burden and testing rates, health service configuration, and implementation strategy</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07943aca52bd8242fc7cba857f665e6b"><gtr:id>07943aca52bd8242fc7cba857f665e6b</gtr:id><gtr:otherNames>Dangerfield C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>58b96ef6456352.55888782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8163C75E-45CF-44D2-AC06-CBD6B8AC1190</gtr:id><gtr:title>P116 How Common is Rectal
 
 Infection in Women? A Systematic Review, 1997 to 2015: Abstract P116 Table 1</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2747a649c892cf54744863965e644f1"><gtr:id>a2747a649c892cf54744863965e644f1</gtr:id><gtr:otherNames>Nastassya L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b96ef5a8e236.64476126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>165C9D78-0034-49D6-BB96-0ADE6C9BEE82</gtr:id><gtr:title>A user-centred approach to inform the design of a mobile application for STI diagnosis and management</gtr:title><gtr:parentPublicationTitle>Proceedings of the BCS British HCI Group Annual Conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a08dfe045fab91dde38932cfb1d271b"><gtr:id>2a08dfe045fab91dde38932cfb1d271b</gtr:id><gtr:otherNames>Gkatzidou V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>54661b0ddfee81.19033983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7C98EA3-C059-4B52-84DB-5E308017E777</gtr:id><gtr:title>Continuous Flow Pressure Driven Microfluidic Techniques for Point of Care Testing</gtr:title><gtr:parentPublicationTitle>Sensors and Transducers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e588d4d3499cd2b82fa3a5aab783b3cc"><gtr:id>e588d4d3499cd2b82fa3a5aab783b3cc</gtr:id><gtr:otherNames>Ereku, T.E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>KbhaqNfmTkU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39D58204-31F2-46D7-B826-B8661041D62C</gtr:id><gtr:title>Modular development of a prototype point of care molecular diagnostic platform for sexually transmitted infections.</gtr:title><gtr:parentPublicationTitle>Medical engineering &amp; physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f105808e383771e5cbb19e2277f4c9bf"><gtr:id>f105808e383771e5cbb19e2277f4c9bf</gtr:id><gtr:otherNames>Branavan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-4533</gtr:issn><gtr:outcomeId>583ebed58433f2.48916604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD99245C-AF0D-477E-B3CE-0AF81A057D20</gtr:id><gtr:title>Mixed-methods evaluation of a novel online STI results service.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>5a9675dbc02b95.36864905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F939473-B23E-499F-883C-FCB13CEE1BFC</gtr:id><gtr:title>P111 A user centred approach to the design of point-of-care and self-test mobile phone diagnostics for sexually transmitted infections (STIs)</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a44546b4698c4abfc70cc404ad21bb7"><gtr:id>3a44546b4698c4abfc70cc404ad21bb7</gtr:id><gtr:otherNames>Voula G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56e0598c14bfb5.81681413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69197276-0F34-4F9F-ACEB-D996F4802911</gtr:id><gtr:title>001 PP: ONLINE CLINICAL MANAGEMENT PATHWAYS FOR CHLAMYDIA TREATMENT: ENRICHING FORMATIVE EVALUATION OF A COMPLEX E-HEALTH INTERVENTION</gtr:title><gtr:parentPublicationTitle>BMJ Open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7d6095f02fd97306e51f12e9d86e626"><gtr:id>d7d6095f02fd97306e51f12e9d86e626</gtr:id><gtr:otherNames>Aicken C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56c1b570f1c5e0.39019224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51159DC2-E021-42AD-AE6E-867DE97979E6</gtr:id><gtr:title>Chlamydia testing: where are we now? Recruiting high-risk women to a pilot STI screening trial.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/604c9d36244024eb93ed9e17fe8cb6fa"><gtr:id>604c9d36244024eb93ed9e17fe8cb6fa</gtr:id><gtr:otherNames>Hunjan T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_13576_26_24123869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2657E6D1-B23C-48D2-8DC8-20AB46B9E66B</gtr:id><gtr:title>O14.1 Is an automated online clinical care pathway for people with genital chlamydia (chlamydia-occp) within an esexual health clinic feasible and acceptable? proof of concept study</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77fd56d4e7327863ca5edf7da7ef39b8"><gtr:id>77fd56d4e7327863ca5edf7da7ef39b8</gtr:id><gtr:otherNames>Estcourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>564319ca684929.66340411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5D73774-01F7-4775-B542-5FB029FBC5AD</gtr:id><gtr:title>The eClinical Care Pathway Framework: a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections.</gtr:title><gtr:parentPublicationTitle>BMC medical informatics and decision making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-6947</gtr:issn><gtr:outcomeId>585d68b25bf442.90825304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9D20E99-E847-4EA0-8B82-50F194C52122</gtr:id><gtr:title>Proceedings: Eighth Meeting of the European Society for Chlamydia Research, Oxford, UK, September 6-9, 2016</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b9732d298022.02889351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A286B9B-0ABF-4C21-8062-5FFF94F34922</gtr:id><gtr:title>O034 Whole genome sequencing to predict
 
 antibiotic susceptibility: toward tailored antimicrobial therapy</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fbcb5c843556427f664a79afc3a959c"><gtr:id>0fbcb5c843556427f664a79afc3a959c</gtr:id><gtr:otherNames>Phillips L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b93a1d4fade8.82787935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F661FC92-538D-4E25-BF80-CEFCBB1E0F6D</gtr:id><gtr:title>Chlamydia related bacteria (Chlamydiales) in early pregnancy: community-based cohort study.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50ffd93ca63e09e06ec43e39b3e598ce"><gtr:id>50ffd93ca63e09e06ec43e39b3e598ce</gtr:id><gtr:otherNames>Reid F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>5a35e51cea4472.79953139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD5AEAA-9429-4CC3-9AAF-305DAB60E1A0</gtr:id><gtr:title>Exploring access and attitudes to regular sexually transmitted infection screening: the views of young, multi-ethnic, inner-city, female students.</gtr:title><gtr:parentPublicationTitle>Health expectations : an international journal of public participation in health care and health policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3fb9e4691cc6205c7575be0397fcff8"><gtr:id>c3fb9e4691cc6205c7575be0397fcff8</gtr:id><gtr:otherNames>Normansell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1369-6513</gtr:issn><gtr:outcomeId>585d590b39bfe0.52487819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C9FDBF1-654B-4BD2-ABC8-D7372539F148</gtr:id><gtr:title>Chlamydia testing: Reaching high-risk sexually active young people in the community.</gtr:title><gtr:parentPublicationTitle>International journal of STD &amp; AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78b68f91f21b598db29d0408b5e8b55b"><gtr:id>78b68f91f21b598db29d0408b5e8b55b</gtr:id><gtr:otherNames>Sharman N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0956-4624</gtr:issn><gtr:outcomeId>56c1cb3fbde7d3.58290615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E77546-C33E-48A1-A8C2-3B2CADD6F19E</gtr:id><gtr:title>User interface design for mobile-based sexual health interventions for young people: design recommendations from a qualitative study on an online Chlamydia clinical care pathway.</gtr:title><gtr:parentPublicationTitle>BMC medical informatics and decision making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a08dfe045fab91dde38932cfb1d271b"><gtr:id>2a08dfe045fab91dde38932cfb1d271b</gtr:id><gtr:otherNames>Gkatzidou V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1472-6947</gtr:issn><gtr:outcomeId>56e05c9fc73605.57129715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F786A22F-E5C4-40A6-8C04-1703227DF8B9</gtr:id><gtr:title>'Can you recommend any good STI apps?' A review of content, accuracy and comprehensiveness of current mobile medical applications for STIs and related genital infections.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>5838348e574b61.43709044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD65D28-3534-4D19-8E39-92D4DE716F50</gtr:id><gtr:title>Are we up to it ? Microbiology and the challenge of sexually transmitted infections</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0e8d567f1781a468f12cf47f49c9ddc"><gtr:id>c0e8d567f1781a468f12cf47f49c9ddc</gtr:id><gtr:otherNames>Burns</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>9780953683895</gtr:isbn><gtr:outcomeId>58c7bc914c3249.56761125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB6F6D72-E0C6-4C60-AFA0-2D5A57E0C6EB</gtr:id><gtr:title>Using the eSexual Health Clinic to access chlamydia treatment and care via the internet: a qualitative interview study.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/775ed2d390c1cb441feecc4f65d6a960"><gtr:id>775ed2d390c1cb441feecc4f65d6a960</gtr:id><gtr:otherNames>Aicken CRH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>5a96752d68ffc9.34255542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>445456F0-A1AE-4111-A228-0E562EBB051F</gtr:id><gtr:title>Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluation.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54f02687a15e5de14772b342776bb860"><gtr:id>54f02687a15e5de14772b342776bb860</gtr:id><gtr:otherNames>Harding-Esch EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>58b8447aac8568.50184341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB87FCEE-F78B-4D52-8895-069AE9ED0FA9</gtr:id><gtr:title>Self-sampling and self-testing for STIs and HIV: the case for consistent nomenclature.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54f02687a15e5de14772b342776bb860"><gtr:id>54f02687a15e5de14772b342776bb860</gtr:id><gtr:otherNames>Harding-Esch EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>585d3b7f3e2c32.70035792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FCC5778-DBFD-468C-8A48-FA1733854C87</gtr:id><gtr:title>P04.26 Robustness of capturing behavioural and sexual lifestyle data for a complex clinical study using internet-based computer assisted self-interview</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5d4322ad2c14e3dd60b89dd6894840c"><gtr:id>c5d4322ad2c14e3dd60b89dd6894840c</gtr:id><gtr:otherNames>Nori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56431c2362ed84.90127373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2012F935-99FA-4543-87DF-C6FD0F169CE3</gtr:id><gtr:title>P07.06 A low cost, hand-held point of care molecular diagnostic device for sexually transmitted infections</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a569bf8283087973fdc15d784e87c21"><gtr:id>5a569bf8283087973fdc15d784e87c21</gtr:id><gtr:otherNames>Mackay R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>564311944ba7d8.53676305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E4FFA14-5B8F-4664-8295-894621608B8B</gtr:id><gtr:title>O15.3 Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising the treatment of gonorrhoea</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a96c80777f2d7.52285530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D34CD5F2-6A09-48F3-B5AE-6968E3883B96</gtr:id><gtr:title>P08.29 Web-tool to assess the cost-effectiveness of chlamydia point-of-care tests at the local level</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56432356df4218.41543082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4B8E080-4A67-498A-81FB-BE603EF33381</gtr:id><gtr:title>P12.02 Developing and using the eclinical care pathway framework: a novel tool for creating online clinical care pathways and its application to management of genital chlamydia</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>564324e475bb98.65051138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A889B50-CB48-4CDF-92BC-59D0646E76A5</gtr:id><gtr:title>A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54f02687a15e5de14772b342776bb860"><gtr:id>54f02687a15e5de14772b342776bb860</gtr:id><gtr:otherNames>Harding-Esch EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn><gtr:outcomeId>5a9675dba42050.27785301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B449FC55-0C50-44C6-BAF9-8BA0EA3AE38D</gtr:id><gtr:title>RPA using a multiplexed cartridge for low cost point of care diagnostics in the field.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f0d8c7536b9430b18cadcac21057c7f"><gtr:id>6f0d8c7536b9430b18cadcac21057c7f</gtr:id><gtr:otherNames>Ereku LT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn><gtr:outcomeId>5a995f44420c46.34010092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>061E027B-452C-496F-840C-484C7CC82ED5</gtr:id><gtr:title>Improving clinical governance of HIV treatment programmes in resource poor settings: the role of digitising clinical notes.</gtr:title><gtr:parentPublicationTitle>International journal of STD &amp; AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/854c88435bad4b144824451a41e560a2"><gtr:id>854c88435bad4b144824451a41e560a2</gtr:id><gtr:otherNames>Cohen DY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0956-4624</gtr:issn><gtr:outcomeId>pm_13576_26_23970598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7A16F8-164D-490B-8B03-09D849E76834</gtr:id><gtr:title>A Nucleic Extraction Method for Point of Care Diagnostics</gtr:title><gtr:parentPublicationTitle>microTAS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/890bbafb9fb71ab8267657b03977b013"><gtr:id>890bbafb9fb71ab8267657b03977b013</gtr:id><gtr:otherNames>MacKay RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>54647d50c6de44.03269742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD5E956A-4087-468D-BE06-D49261725B5C</gtr:id><gtr:title>Performance evaluation of automated urine microscopy as a rapid, non-invasive approach for the diagnosis of non-gonococcal urethritis.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/677dbd658e15e70352207a50856620c2"><gtr:id>677dbd658e15e70352207a50856620c2</gtr:id><gtr:otherNames>Pond MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>54637db80a18e3.92803377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>430FC8D8-49C4-4A51-B25C-7C992A367226</gtr:id><gtr:title>P2.163 Do &amp;quot;In-Clinic&amp;quot; Molecular and Non-Molecular Rapid Tests Improve Patient Management?: Abstract P2.163 Table 1</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5463783b9c12f2.42523600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F20E8C73-E429-4A21-9C6E-B98EA41FE519</gtr:id><gtr:title>Use of the Internet for Sexual Health Among Sexually Experienced Persons Aged 16 to 44 Years: Evidence from a Nationally Representative Survey of the British Population.</gtr:title><gtr:parentPublicationTitle>Journal of medical Internet research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3aadb7cac30608485e670e5d0b39f1c"><gtr:id>d3aadb7cac30608485e670e5d0b39f1c</gtr:id><gtr:otherNames>Aicken CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1438-8871</gtr:issn><gtr:outcomeId>56c1b239bd4e41.76317751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D25F3C2B-2884-4F3F-B3E6-FD47E42724C6</gtr:id><gtr:title>O19.2 Mycoplasma Genitalium is as Frequent a Cause of Urethritis as Chlamydia Trachomatis, and Has High Rates of Genotypic Resistance to Macrolide Antibiotics</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed182e32814b009088adef9fced1314"><gtr:id>aed182e32814b009088adef9fced1314</gtr:id><gtr:otherNames>Pond M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546373aedd0ad4.53596485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AFE85C1-A929-43A9-BBB7-1E14A788DCE8</gtr:id><gtr:title>P209 Outcomes of partner notification (PN) for sex partners of people with chlamydia, managed via the</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5838348e2cdd20.64185197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A7897A9-8188-43EE-8952-96B6CBE61EF7</gtr:id><gtr:title>Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53b3d7f444c6d7b77494d98ac1274ccb"><gtr:id>53b3d7f444c6d7b77494d98ac1274ccb</gtr:id><gtr:otherNames>Oakeshott P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>gkExozz9UY6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7753B48-01D6-4678-8E70-F7E5AB88DE31</gtr:id><gtr:title>Development of an Electronic Prescribing System Linking Sexual Health Services and Community Pharmacies to Support an Online Clinical Consultation for Remote Management of People with Genital Chlamydia Trachomatis within the eSTI2 Consortium</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546380d49ee322.25314167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE547DD-E568-460B-BD86-DB4C750B3059</gtr:id><gtr:title>P22 A user centred approach to the design of p-of-care and self-test mobile phone diagnostics for sexually transmitted infections (STIs)</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a08dfe045fab91dde38932cfb1d271b"><gtr:id>2a08dfe045fab91dde38932cfb1d271b</gtr:id><gtr:otherNames>Gkatzidou V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>54661eb104e135.86737839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8906ACA1-0EB0-4B40-B6EA-D213FE93180A</gtr:id><gtr:title>P1.012 Urinary Cytokine Profiles in Non-Specific, Mycoplasma Genitalium and Chlamydia Trachomatis Urethritis</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed182e32814b009088adef9fced1314"><gtr:id>aed182e32814b009088adef9fced1314</gtr:id><gtr:otherNames>Pond M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>54637a775bf0e8.27195219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76AEE20C-F919-4B83-9812-3EE9944B3BB6</gtr:id><gtr:title>P170 Risk factors for
 
 infection in symptomatic males, females and men who have sex with men from three clinical settings in London: Abstract P170 Table 1</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd2d84ec50087e9c008e0c593d555d27"><gtr:id>bd2d84ec50087e9c008e0c593d555d27</gtr:id><gtr:otherNames>Broad C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b96ef61ca998.92426495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9395E4B0-61C6-4C37-AAD4-F0453A735977</gtr:id><gtr:title>P12.03 How accurate and comprehensive are currently available mobile medical applications (apps) for sexually transmitted and genital infections: a comprehensive review</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5643242e998e42.86524839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FC9100E-6619-47F2-BECA-700F1EAC2EF6</gtr:id><gtr:title>Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a21e21d4da9078fb60b8b01070e1c486"><gtr:id>a21e21d4da9078fb60b8b01070e1c486</gtr:id><gtr:otherNames>Craw P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn><gtr:outcomeId>pm_13576_26_22592150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A50760-6599-4D54-BA16-FF7696378FA9</gtr:id><gtr:title>Proceedings: Eighth Meeting of the European Society for Chlamydia Research, Oxford, UK, September 6-9, 2016</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b11767e3117d4b6c4a2e0bbe8f32611c"><gtr:id>b11767e3117d4b6c4a2e0bbe8f32611c</gtr:id><gtr:otherNames>Cousins E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b972cd674d02.86478952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4C5A416-D515-4EC0-A30A-95FDC4B28877</gtr:id><gtr:title>P200 A facility to enable high-quality, time-efficient evaluations of diagnostics for stis</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2f9567f57ee6236d9fc7554657551a"><gtr:id>7e2f9567f57ee6236d9fc7554657551a</gtr:id><gtr:otherNames>Harding-Esch E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>58b96ef6a58d54.79494570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>310ECBBB-B8B7-4972-AE57-FA4087EB4F8C</gtr:id><gtr:title>Research benefits of storing genitourinary samples: 16S rRNA sequencing to evaluate vaginal bacterial communities.</gtr:title><gtr:parentPublicationTitle>International journal of STD &amp; AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebbebd92a0fd62aab5ba8726acb881cc"><gtr:id>ebbebd92a0fd62aab5ba8726acb881cc</gtr:id><gtr:otherNames>Wagner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0956-4624</gtr:issn><gtr:outcomeId>58b8447a75d666.73258987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98AAF821-ED1E-420D-98A0-1682CC7E012F</gtr:id><gtr:title>2nd BASHH Oxford Diagnostics Course, November 2015.</gtr:title><gtr:parentPublicationTitle>International journal of STD &amp; AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45fae03a3ab0c9dcf49676563401bea9"><gtr:id>45fae03a3ab0c9dcf49676563401bea9</gtr:id><gtr:otherNames>Patel RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0956-4624</gtr:issn><gtr:outcomeId>56c1cb17923b94.70337471</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901608</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>B7F5A9CA-62C7-4E68-A2B2-3D6CCA85E16B</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>7.3  Management and decision making</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>